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Introduction: Dental biofilm is the main reason for several oral diseases such as caries and periodontitis. 
Therefore, there is a high demand for preventative strategies such as the use of chemical agents for the 
control of dental biofilm. As a consequence, it is always a priority interest and an important research 
area in the field of dentistry to evaluate and compare the effectivity of different antibacterial agents and 
to investigate the retention, stability, and efficacy of different treatment regimens.  
Objective: This in situ study aims to determine the retention of chlorhexidine in different oral locations 
after the application of various chlorhexidine regimens. Furthermore, it seeks to investigate and compare 
the anti-biofilm efficacy of chlorhexidine (CHX) and octenidine (OCT) mouth rinses. 
Material and Methods: Five volunteers were recruited for this work. In the first retention experiment, 
the samples were taken with micro-brushes from the interdental area, buccal dental pellicle, anterior 
labial and posterior buccal mucosa, as well as saliva at five-time points within 24 h after mouth rinsing 
with 10 ml of 0.2% CHX for 30 s. In the second retention experiment, the volunteers used different 
CHX treatment regimens from mouth rinses, dental spray, or toothpaste. After application, 2 µl samples 
were taken from the saliva and buccal mucosa pellicle in addition to the dental pellicle sample formed 
on a standardized enamel surface. The samples were taken at six-time points within 12 h. Retention of 
CHX in the aforementioned experiments was measured using Matrix-assisted Laser 
Desorption/Ionization-Time of Flight (MALDI-TOF) mass spectrometry.  
In the second part of this work, biofilms were formed in the anti-biofilm experiment in situ on bovine 
enamel surfaces fixed to individual acrylic splints. For biofilm formation analysis, the subjects 
intraorally exposed the splint for 48 h. Mouth rinses were done using 10 ml of 0.1% CHX, 0.2% CHX, 
0.1% OCT, or water as control. Each rinsing was performed every 12 h for 30 s. Biofilm colonization 
and bacterial vitality were investigated at 24 and 48 h. For analysis of biofilm disruption activity, the 
evaluation of 48 h-mature biofilms was performed before and directly after the first CHX rinse in both 
concentrations or OCT rinse and repeated 24 h later for the 72 h-mature biofilms. The coverage, vitality, 
and ultrastructure assessments of biofilm samples were performed by fluorescence microscopy and 
transmission electron microscopy. 
Results: A significant reduction of the intraoral CHX concentration was detected during the first 6 h. 
Thereafter, CHX retained in the oral cavity at low concentrations of micrograms per millilitre levels for 
12 h after application. CHX was even detected 24 h after oral rinsing. CHX retention in the oral mucosa 
and dental pellicle was significantly higher than the retention in saliva. The retention of CHX after 
mouth rinsing or spray application was higher compared to the retention after the use of toothpaste.  
Rinses with 0.1% CHX, 0.2% CHX, or 0.1% OCT caused a significant reduction in the biofilm 
formation on enamel surfaces. Bacterial colonization and vitality were both clearly reduced. Moreover, 
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a remarkable biofilm disruption was observed due to the application of CHX or OCT rinses. 
Interestingly, only one application of CHX or OCT to a 48-h mature biofilm induced biofilm 
ultrastructure modification and significantly reduced the biofilm thickness and microbial vitality. 
Conclusion: It was found in the present work that the MALDI-TOF technique provides excellent 
quantification limits for the CHX determination. It allows the detection of CHX without the need for 
time-consuming sample preparation. The obtained results indicate that dental pellicle and oral mucosa 
are the essential reservoirs of CHX in the oral cavity. With time, the CHX is desorbed from the oral 
surfaces toward saliva to produce a persistent bacteriostatic effect in the whole oral cavity. Moreover, 
the results show that there are significant differences in CHX retention after the application of different 
CHX regimens; mouth rinses, dental spray, and toothpaste.  
It also was concluded in this work that the mouth rinses based on CHX in both concentrations 0.1% and 
0.2% as well as 0.1% OCT have a significant effect on reducing biofilm formation confirmed through 
the reduction of the oral bacterial colonization and biofilm vitality on native enamel specimens. 
Additionally, this study demonstrates an important biofilm disruption effect of the CHX and OCT 
rinsing, since they were effective to dislodge pre-existing biofilms, even in the total absence of 
mechanical biofilm management. However, 0.1% OCT showed significantly better results in anti-
biofilm activity in comparison with CHX at the same concentration. 
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1.2 German 
Einleitung: Der bakterielle Biofilm ist die häufigste Ursache oraler Erkrankungen wie Karies und 
Parodontitis. Präventive Strategien zur Kontrolle des Biofilms beinhalten neben der mechanischen 
Plaqueentfernung insbesondere die Anwendung chemischer Substanzen. Ein besonderes Interesse der 
zahnmedizinischen Forschung liegt in der Bewertung und dem Vergleich der Wirksamkeit, der 
Retention und der Stabilität verschiedener antimikrobieller Wirkstoffe. 
Ziel: Diese in situ-Studie hat zum Ziel, die Retention von Chlorhexidin in verschiedenen oralen 
Regionen nach Anwendung unterschiedlicher Behandlungsschemata zu bestimmen. Darüber hinaus soll 
die Anti-Biofilm-Aktivität von Chlorhexidin (CHX) und Octenidin (OCT)- Mundspülungen untersucht 
und miteinander verglichen werden. 
Material und Methoden: An dieser Studie haben fünf Probanden teilgenommen. Für das erste 
Retentionsexperiment haben die Probanden 10 ml 0,2% CHX als Mundspüllösung intraoral für 30 s 
appliziert. Anschließend wurden Proben aus dem Interdentalbereich, der bukkalen Dentalpellikel, der 
vorderen labialen und hinteren bukkalen Mukosa sowie dem Speichel mit einer Mikrobürste an fünf 
verschiedenen Zeitpunkten innerhalb von 24 h entnommen. Im zweiten Retentionsexperiment 
verwendeten die Probanden verschiedene CHX-Applikationsformen wie Mundspülungen, Mundspray 
und Zahnpasta. Nach der Anwendung wurden Proben an sechs Zeitpunkten innerhalt von 12 h 
gesammelt. Zusätzlich zu der Dentalpellikel auf Schmelzprüfkörpern wurden je 2 µl Probe vom Speichel 
und der bukkalen Mukosa entnommen. Die Retention von CHX wurde in den oben genannten 
Experimenten mittels Matrix-unterstützter Laser-Desorption/Ionisation-Flugzeit (MALDI-TOF) 
Massenspektrometrie gemessen.  
Im zweiten Teil dieser Studie, einem Anti-Biofilm-Experiment, erfolgte die Biofilmbildung in situ auf 
bovinen Schmelzprüfkörpern. Diese Prüfkörper wurden an Kunststoffschienen fixiert und für 48 h 
intraoral exponiert. Für Mundspülungen wurden je 10 ml 0,1% und 0,2% CHX sowie 0,1% OCT oder 
Wasser als Kontrolle verwendet. Die Applikation der Testlösung fand alle 12 h für 30 s statt. Die 
Biofilmbildung und die bakterielle Vitalität wurden nach 24 h und 48 h evaluiert. Um den Einfluss der 
CHX- und OCT-Mundspülung auf den reifen Biofilm zu beurteilen, wurde der Biofilm auf bovinen 
Schmelzproben für 48 h gebildet. Danach wurde die Mundspüllösungen 0,1% und 0,2% CHX oder 0,1% 
OCT intraoral appliziert. Die zweite Applikation der getesteten Substanzen erfolgte nach weiteren 12 h. 
Die Biofilm-Ultrastruktur und die bakterielle Vitalität wurden nach 48 h direkt vor und nach dem Spülen 
sowie nach 72-h intraorale Expositionszeit evaluiert. Die Vitalität des Biofilms wurde nach der 
Vitalfärbung fluoreszenzmikroskopisch analysiert. Zusätzlich wurde die Ultrastruktur des Biofilms 
mittels Transmissionselektronenmikroskopie untersucht.  
Ergebnisse: Die stärkste Abnahme von CHX erfolgte während der ersten 6 h, danach sank die 
Konzentration in geringerem Maße ab. CHX war in der Konzentration von einem Mikrogramm pro 
Milliliter für mindestens 12 h nachweisbar und konnte sogar 24 h nach der Anwendung nachgewiesen 
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werden. Die CHX-Retention in der Mukosa und in der Dental pellikel war signifikant höher als im 
Speichel. Die CHX-Retention nach der Mundspülung oder der Sprayapplikation war wesentlich höher 
als nach der Verwendung der Zahnpasta.  
Spülungen mit 0,1% CHX, 0,2% CHX oder 0,1% OCT führten zu einer deutlichen Reduktion der 
Biofilmbildung auf dem Zahnschmelz. Sowohl die Besiedlung als auch die Viabilität der Bakterien 
waren signifikant beeinträchtigt. Darüber hinaus wurde eine starke Disruption des Biofilms durch die 
CHX- oder OCT-Spülungen beobachtet. Bemerkenswerterweise bewirkt bereits eine einmalige 
Anwendung von CHX oder OCT bei einen 48 h alten Biofilm eine substantielle Veränderung der 
Ultrastruktur und induziert eine Reduktion der Biofilmdicke und der bakteriellen Vitalität. 
Schlussfolgerung: Die vorliegende Studie zeigte, dass die verwendete MALDI-TOF Methode zur 
CHX-Bestimmung hervorragende Quantifizierungsgrenzen bietet und eine schnell durchführbare CHX-
Quantifizierung ohne zeitaufwendige Probenvorbereitung erlaubt. Die Ergebnisse weisen darauf hin, 
dass die Mukosa und die Pellikel als das Hauptreservoir für CHX fungieren. Durch eine kontinuierliche 
Freisetzung von CHX in den Speichel können diese Reservoirs den bakteriostatischen Effekt von CHX 
in der Mundhöhle verlängern. Jedoch gibt es signifikante Unterschiede in der CHX-Retention zwischen 
der Mundspülung, dem Mundspray und der Zahnpasta. 
Im Rahmen dieser Studie wurde auch gezeigt, dass das Spülen mit CHX in beiden Konzentrationen 
0,1% und 0,2% sowie mit 0,1% OCT die Entstehung des bakteriellen Biofilms stark hemmt. Darüber 
hinaus wurde ein wichtiger Disruptionseffekt der CHX- und OCT-Spülungen auf den reifen Biofilm 
demonstriert. Allerdings zeigte 0,1% OCT signifikant bessere Ergebnisse bei der Anti-Biofilm-Aktivität 
im Vergleich zu CHX bei gleicher Konzentration. 
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2 Introduction 
Dental biofilm is the main cause of several oral diseases, such as caries (TAKAHASHI, NYVAD, 2008; 
COLOMBO, TANNER, 2019) and periodontal diseases (LÖE et al., 1965; LARSEN, FREIHN, 2017). 
These diseases are common in the world and still a public health issue for a large part of the world’s 
population (BURT, 1998). Thus, there is a strong need for primary preventive strategies. The keystone 
of these strategies is the control of dental biofilm. The most widely used method for dental biofilm 
control is mechanical cleaning. The standard tools used for mechanical cleaning are the toothbrush 
(manual or electric), floss, and interdental brushes. However, mechanical cleaning is efficient only in 
places, where access to biofilm sediments is possible. Additionally, the majority of the patients do not 
have the degree of motivation and skills needed even for the regular oral hygiene procedures (LINDHE, 
KOCH, 1967). Therefore, acceptable biofilm management by mechanical measures is hard to be 
achieved by most persons, especially by individuals with periodontitis, who have deep periodontal 
pockets, and disabled persons, for whom appropriate oral hygiene is a non-realistic goal (LOUISE et al., 
2017). Therefore, supportive treatment for biofilm management would be required. 
In this context, antibacterial products are often described in situations where oral hygiene measures 
are difficult, compromised, or impossible (ADDY, MORAN, 1997). In other words, the use of 
chemically active substances can be a valuable tool for biofilm control when the manual procedures are 
not used long enough or on a regular daily basis to achieve the appropriate elimination of dental biofilm 
(MANDEL, 1988; TAKENAKA et al., 2019). The major goal of the antiseptics is to preserve, enhance, 
or even replace both preventive and therapeutic mechanical measures (TEN CATE, MARSH, 1994).  
To enhance the use of these agents, several studies have been done and techniques have been used 
to evaluate different antiseptics. These studies either determine the agents’ retention and stability after 
application or to evaluate the antimicrobial effects on dental biofilm. Additionally, experimental 
researches were performed to obtain more information about the behaviour and mechanism of action 
behind the efficacy of oral antiseptics. 
Therefore, the aim of this work was to determine the retention of the gold standard chlorhexidine 
in different oral locations, especially after the application of different chlorhexidine formulations. 
Additionally, we aimed to evaluate and compare the anti-biofilm efficacy and biofilm disruption activity 
of two antimicrobial agents, chlorhexidine and octenidine. 
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2.1 Review of literature 
2.1.1 Dental pellicle 
2.1.1.1 Formation of the pellicle 
After tooth surface cleaning, by way of tooth brushing or professional prophylaxis, salivary 
macromolecules begin to adsorb at the dental surface immediately. This adsorption will form a 
conditioning film which termed the acquired pellicle (HANNIG, 1999; LANG et al., 2008). The 
selective adsorption of salivary proteins on the tooth surface plays an essential role in building the thin 
film of an acquired pellicle (LENDENMANN et al., 2000). Previously, it was believed that the pellicle 
film is basically from the embryologic origin (NASMYTH, 1839). However, it was discovered in the 
middle of the 20th century, that the pellicle is acquired after tooth eruption. Since then, it has been stated 
that the embryologic membrane is lost after the eruption of the teeth and is replaced by an acquired 
coating that mainly consists of positively charged groups of salivary proteins (TRAUTMANN et al., 
2020). 
2.1.1.2 Chemical and ultrastructural composition of the pellicle 
The experimental studies which are investigating the pellicle composition are hampered due to the small 
amount of dental pellicle which can be collected and analysed (HANNIG, JOINER, 2006). The early 
obtained results allowed concluding that the dental pellicle is mainly conducted from salivary 
glycoproteins (mucins). Later, improved techniques for harvesting dental pellicle have been introduced. 
These methods combined both mechanical and chemical harvesting of the pellicle which permitted the 
determination of a lot of salivary and fewer non-salivary elements as ingredients of the dental pellicle 
(Al-HASHIMI, LEVINE, 1989; CARLEN et al., 1998; TRAUTMANN et al., 2019).  
Furthermore, Carlen and co-workers showed that there is a high similarity in the protein profile 
between the dental pellicles from different parts of the oral cavity and the locally available salivary 
biopolymers (CARLEN et al., 1998). These results indicate that the locally salivary protein patterns play 
an essential role in the formation and composition of the dental pellicle layer. However, it was found 
also that there are some differences in the fatty acid profile between saliva and the dental pellicle. These 
findings indicate that the formation of the dental pellicle is a highly selective process and lipids available 
in saliva are not adsorbed equivalently to the pellicle layer (REICH et al., 2013). 
Regarding the chemical composition, the pellicle samples consist of 46% amino acids, 14% total 
carbohydrates, and 2.7% hexosamines in addition to salivary α-amylase, lysozyme, immunoglobulins, 
and mucins (ARMSTRONG, 1967; AL-HASHIMI, LEVINE, 1989). Recently, a total of 1188 different 
proteins were identified on only 3 min old initial human pellicle (TRAUTMANN et al., 2019). 
Furthermore, with time, there are significant qualitative and quantitative proteome changes during the 
acquired enamel pellicle formation. In the end, the acquired pellicle will play an important role in the 
formation of dental biofilms (LEE et al., 2013). 
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Little information is available about lipids in the dental pellicle although they formed almost 22% 
of the pellicle’s dry weight (HANNIG, JOINER, 2006). In general, glycolipids are the main lipid portion 
of the pellicle which in turn consider as the source for pellicle glucose (KENSCHE et al., 2013). 
Phospholipids were also found in the pellicle such as phosphatidylcholine, phosphatidylethanolamine, 
and sphingomyelin (SLOMIANY et al., 1986). The existence of phospholipids is proposed to have an 
important role in the consistency of the pellicle (SLOMIANY et al., 1990).  
Electron microscopy is used to examine the structural composition of the dental pellicle. It was 
reported in previous studies that the pellicle thickness ranges between 100 and 1300 nm on enamel 
surfaces. The pellicle thickness varies upon the location of the surface in the oral cavity, the age, and 
the maturity of the pellicle (TINANOFF et al., 1976; HANNIG, 1999). 
Previous studies suggested that pellicle formation reaches equilibrium between adsorption and 
desorption of salivary proteins within almost 2 h. Consequently, no additional increase in amino acid 
amount was detected after 120 min (SONJU, RÖLLA, 1973; LAMKIN et al., 1996). In contrast, another 
study showed that pellicle formation is not complete after 2 h because of further accumulation of salivary 
biopolymers that do not reach a plateau of adsorption on the dental surfaces after a 2-h period (HANNIG, 
1999). Based on the morphologic criteria, the dental pellicles consist of two layers: 
1) A direct electron-dense basal layer as a result of the direct, initial phase of salivary protein adsorption 
onto the tooth surface. 
2) The outer layer that forms as a consequence of additional adsorption of salivary proteins which 
resulted in the formation of a less dense loosely arranged pellicle layer (HANNIG, 1999). This outer 
layer varies in more than one complex ultrastructural pattern. One of the patterns is the globular pellicle, 
which is characterized by a consistent presence of globules of different sizes and configurations. These 
globules are distinctly different from microorganisms because of the dimensions, contour, and absence 
of cell membrane. Another pattern is the fibrillar micelle-like structure pellicle, which consists of 3- to 
7-nm wide fibrils and often includes some finely globular particles. The last pattern is the granular 
structure layer, which is usually seen after 12 h with a relatively smoother surface. This granular pellicle 
does not exhibit globular or fibrillary structures, but it instead contains distinct laminations. Apparently, 
the variation on pellicle morphology is a reflection of its time-dependent, complex chemical 
composition, oral location effect, and the influence of shearing forces in this location (LIE, 1977; 
HANNIG, 1999). 
2.1.1.3 Functions of the pellicle 
Two important aspects have been studied in regards to the acquired pellicle functions:  
1) The acquired pellicle plays an important role in enamel protection in two fields: First, by resisting the 
acid-induced demineralization. Several previous studies proved that salivary pellicle considerably 
reduces enamel erosion and mineral loss by acidic drinks (MEURMAN, FRANK, 1991) or orange juice 
Introduction 
- 8 - 
 
(AMAECHI et al, 1999). The acquired pellicle possesses this protective property because of its chemical 
components. For example, the proteins inside even a 3-min initial pellicle are resistant to removal by an 
acidic attack. Moreover, 120-min pellicles possess more protective proteins that are resistant to removal 
which can suggest an increase in protection against acid attacks with the time of pellicle formation 
(HEGDE, SAJNANI, 2017; TAIRA et al., 2018). Dental surface demineralization is rarely seen because 
of the protective effects of the acquired pellicle in spite of the continuous consumption of acidic drinks. 
Secondly, it is also believed that acquired pellicle plays an important role in enamel protection by 
reducing friction and abrasion between teeth, it also protects between teeth and the oral mucosa, 
especially during mastication and parafunctional habits (LENDENMANN et al., 2000). Furthermore, it 
was demonstrated that acquired pellicle can significantly reduce daily toothpaste abrasion (JOINER et 
al., 2008). Interestingly, it was reported that the protective role of the dental pellicle is partly lost after 
using abrasive toothpaste because the pellicle is partly or completely removed with this rigorous oral 
hygiene practice. Therefore, aggressive hygiene procedures should be avoided to preserve the protective 
functions of the dental pellicle (KUROIWA et al., 1992).  
2) The acquired pellicle plays a big role in bacterial adherence and biofilm formation. At first, the pellicle 
film alters the charge and free energy of the dental surface and replaces it with the positively charged 
pellicle proteins. This then attracts the negatively charged microorganisms by electrostatic forces and 
initiates the bacterial adhesion process. Afterward, this pellicle provides several receptors for facilitating 
additional bacterial adhesion. The bacteria, in turn, have special surface constructions such as fimbriae 
and fibrils that assist in the adherent to tooth surfaces. In time, these bacteria will form dental microbial 
biofilm or dental plaque (SOCRANSKY, HAFFAJEE, 2002).  
2.1.2 Dental biofilm  
2.1.2.1 Dental biofilm definition 
Dental biofilm has been defined as a specialized biofilm that consists of a diverse community of 
microorganisms formed on the dental surface (SOCRANSKY, HAFFAJEE, 2002; MARSH, 2004). 
More than 6000 species-level phylotype microorganisms have been identified in this biofilm (KEIJSER 
et al., 2008). They are non-randomly embedded in an extracellular slime matrix, which consists of 
biopolymers of host and bacterial origins, such as polysaccharides, proteins, glycolipids, and DNA 
(MARSH, 2004; FLEMMING et al., 2007). 
2.1.2.2 Ultrastructural composition of the dental biofilm 
As mentioned before, the oral bacteria will use the electrostatic forces and their surface structures to 
attach the tooth surfaces (SOCRANSKY, HAFFAJEE, 2002). At first, the microorganisms will establish 
a thin basal layer on the dental surface. This basis bacterial layer is in contact or occasionally penetrating 
the dental pellicle. While one set of bacterial surface structures, proteins, and extracellular 
polysaccharide mediate the attachment to solid surfaces, a second set of these agents mediate cell-to-
cell relation in building a 3-dimensional form of the dental biofilm (VALM, 2019). With time, this 
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3-dimensional biofilm structure resembles towers or mushrooms towards the lumen of the solution. The 
structure is separated by apparently empty channels, but they are filled with extracellular polysaccharide 
(COSTERTON et al., 1995; SOCRANSKY, HAFFAJEE, 2008). The presence of water channels 
permits the passage of nutrients and waste products within the biofilms. In this way, these channels act 
as a primitive ‘‘circulatory’’ system (SOCRANSKY, HAFFAJEE, 2002).  
It is important to mention that there are specific relationships between the bacteria in dental biofilms 
and the association between them is not random (SOCRANSKY et al., 1998). These relationships are 
represented in facilitating the following: handling and uptake of nutrients, one bacterial species 
providing nutrients for other bacteria (cross-feeding), utilizing and eliminating the potentially harmful 
metabolic components, and establishing a convenient living environment. Moreover, the association 
between different bacterial species and their specific environmental conditions leads to unique growth 
patterns with structurally complex and mature biofilm development. This pattern of biofilm formation 
provides several advantages to the colonizing microorganisms. An important advantage is protecting the 
bacterial species inside the biofilm from environmental factors. These factors include host defence 
procedures and potentially toxic agents in the environment, such as antiseptics or antibiotics 
(SOCRANSKY, HAFFAJEE, 2002). 
The majority of authors who subsequently analysed in situ biofilm emphasized large inter-
individual differences in biofilm thickness (AUSCHILL et al., 2004; DIGE et al., 2009; MARTÍNEZ-
HERNÁNDEZ et al., 2020) and vitality distribution (AUSCHILL et al., 2001; ZAURA-ARITE et al., 
2001; MARTÍNEZ-HERNÁNDEZ et al., 2020). Even variations in biofilm compositions were found in 
samples from different oral locations; for example, anterior versus posterior sites (differing in nutrient 
availability), smooth surfaces versus fissures, or sites near to saliva excretion points (AUSCHILL et al., 
2004). But in general, increasing biofilm age and thickness leads to higher complexity in the dental 
biofilm structure (ZAURA-ARITE et al., 2001; DIGE et al., 2007; MARTÍNEZ-HERNÁNDEZ et al., 
2020).  
Mean microbial vitality values between 60% and 77% had been detected in several in situ studies 
over 2 and 3 day periods (ARWEILER et al., 2004; AUSCHILL et al., 2005; VON OHLE et al., 2010). 
Furthermore, after imaging mature in situ formed biofilms by the confocal microscopy, it was found 
that the living microorganisms were mostly located on the upper layers of the dental biofilm covering 
dense layers of dead microorganisms (NETUSCHIL et al., 1998). 
2.1.2.3 Dental biofilm complications 
If left unremoved, the formation of dental biofilm can lead to severe oral complications and infections 
(KILIAN et al., 2016; LARSEN, FIEHN, 2017), such as caries and periodontal diseases (COLOMBO, 
TANNER, 2019).  
For instance, the primary cause of caries is the microbial carbohydrate catabolism and the release 
of organic acids that induce demineralization of the tooth surfaces (TAKAHASHI, NYVAD, 2008).  
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Periodontal disease is also initiated and sustained by factors (substances) produced by the bacteria 
inside the dental biofilm. Some of these substances are soluble enzymes or harmful bacterial metabolic 
waste products. These products can either directly injure and digest the host’s cells and tissues or initiate 
the host’s immune and inflammatory reactions that cause damage to the periodontal tissues (KINANE 
et al., 2008). 
2.1.3 Dental biofilm management 
Biofilm management is an essential goal in preventive dentistry to eliminate bacterial biofilm. Currently, 
home-use oral care instruments are the most widely used method for dental biofilm elimination. The 
typical instruments used for dental biofilm control are the toothbrush (manual or electric), interdental 
brushes, and floss.  
However, anti-biofilm agents are often recommended in some situations with the unavailability and 
incompetence of mechanical approaches (ADDY, MORAN, 1997), such as for orthodontic patients, 
disabled elders, and post-periodontal surgery patients, etc. (ELEY, 1999). In such situations, the 
chemically active agents are increasingly used as a valuable tool for biofilm management when manual 
biofilm control is compromised or not used in an appropriate way to get adequate oral hygiene 
(TAKENAKA et al., 2019). 
In general, antiseptics have more extended activity than antibiotics because antibiotics tend to have 
certain targets inside the bacterial cells whereas antiseptics are targeting several points on and in 
microbial cells. Moreover, antiseptics can be used with relatively high concentrations directly on the 
oral cavity. Therefore, antiseptics are unlikely to induce microorganism’s resistance (MCDONNELL, 
RUSSELL, 1999). 
It has been stated that antiseptics can reduce biofilm formation in several ways. Antiseptic agents 
can prevent the constitution and growth processes of bacterial biofilm, resolve existing biofilms, or they 
destroy the microorganisms inside the biofilm (ADDY, MORAN, 2008). For an antimicrobial agent to 
have the optimum effect, it should own both a bactericidal effect followed by a bacteriostatic activity. 
The bactericidal effect should happen directly after the application in the oral cavity when the 
antimicrobial agent is at high concentration. This bactericidal effect would be expected to be lost very 
soon after expectoration and prospectively replaced by bacteriostatic activity. This bacteriostatic action 
could remain for a considerable time period in the oral cavity depending on the characteristics of the 
chemical agent (ADDY, MORAN, 2008).  
One of the important features of a chemical agent to be an effective antiseptic in vivo is the 
substantivity, which is defined as the ability of an antimicrobial product to retain its effectiveness in the 
oral cavity for an extended period after application (NETUSCHIL et al., 2003). The efficient 
antimicrobial agent should dramatically reduce the bacterial levels inside the oral cavity to achieve a 
level of bacterial biofilm that will not induce oral diseases or complications.  
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The anti-biofilm mechanisms behind an efficient antiseptic activity are summarized as follows 
(BAEHNI, TAKEUCHI, 2003): 
1) Reduce the bacterial adhesion to the dental surfaces to prevent the biofilm formation.  
2) Reduce the bacterial viability which prevents further growth of the bacterial colonies and interferes 
with the co-aggregation process.  
3) Removal or disruption of an existent biofilm. 
There are numerous of active agents such as chlorhexidine, amine fluoride/stannous fluoride, 
triclosan, and octenidine, which can inhibit biofilm formation, maturation, and microbial proliferation 
(ADDY, MORAN, 2008). But it is important to know that not all of the chemical agents are in the same 
degree in regards to the antibacterial activity and the substantivity after application (MANDEL, 1988; 
TAKENAKA et al., 2019).  
Due to the great effectiveness, the antiseptics chosen to be discussed, investigated, and above all 
compared in this present work were chlorhexidine and octenidine.  
2.1.4 Chlorhexidine 
2.1.4.1 Overview 
Although many products have been used as antiseptics, chlorhexidine (CHX: C22H30Cl2N10) is regarded 
as the most effective antimicrobial agent for chemical control of biofilm formation and for prevention 
of caries for more than 50 years (VAN STRYDONCK et al., 2012). It is one of the most widely used, 
safest, and thoroughly investigated antiseptic (JONES, 1997). In the 1940s, CHX was developed by 
Imperial Chemical Industries in England and marketed in 1954 as an antiseptic for skin wounds 
(DAVIES et al., 1954). 
CHX is a bisbiguanide symmetrical molecule, consisting of four chlorophenyl rings and two 
biguanide groups connected by a central hexamethylene bridge. It can be found in the market in three 
formulations, digluconate, acetate, or hydrochloride salts (ADDY, MORAN, 2008).  
The anti-biofilm activity of CHX in the oral cavity was investigated for the first time in 1970. This 
study showed that using 0.2% CHX-gluconate rinse for 60 s twice per day in the absence of typical teeth 
cleaning prevents biofilm regrowth and the formation of gingivitis (LÖE, SCHIOTT, 1970). 
At physiological pH, CHX is a strong base and a dicationic molecule, with a positive charge on all 
sides of a hexamethylene bridge. Because of that CHX has the ability to adsorb at negatively charged 
surfaces within the oral cavity. It binds to the bacterial cell membrane, where it exerts its bactericidal 
and bacteriostatic effects (JONES, 1997). CHX exhibits a wide spectrum of antibacterial activity that 
targets a wide range of Gram-positive and Gram-negative microorganisms, dermatophytes, and some 
lipophilic viruses, including HBV and HIV. It is active against some fungi and yeasts, including Candida 
(WADE, ADDY, 1989; DENTON, 2001). 
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2.1.4.2 Chlorhexidine mode of action 
At low concentrations, CHX has a bacteriostatic effect due to the immediate attraction to the negatively 
charged targets in the microbial cell membrane. Thereby modifying the integrity of the cell surface, this 
encourages the liberation of low molecular weight substances such as phosphorus and potassium, which 
can lead to partial bacterial damage. Such partial damage prevents bacterial proliferation which in turn 
reduces the bacterial amount available for microbial aggregation and the subsequent formation of oral 
biofilms. CHX-high concentrations induce a bactericidal effect, whereby they damage and rupture 
cytoplasmic membranes, and cause precipitation of cell cytoplasm. This precipitation is caused by an 
interaction between CHX and phosphate entities within the cytoplasm, such as adenosine triphosphate 
and nucleic acids. In this case, CHX dramatically reduces the number of oral bacteria, and it destroys 
all the microorganisms either attaching or already attached to the tooth surface (DENTON, 2001; 
MARTÍNEZ-HERNÁNDEZ et al., 2020).  
CHX has not only the antibacterial effect but also antiplaque activity by using different mechanisms 
of action such as breaking the glycoproteins connections between the bacteria and displacing calcium 
molecules which are considered the glue that binds biofilm particles together (RÖLLA, MELSEN, 
1975). 
2.1.4.3 Chlorhexidine substantivity 
CHX binds most strongly to anionic groups (sulphates, phosphates, and carboxyl groups). This 
capability permits CHX to interact with the oral anionic glycoproteins and phosphoproteins, and adsorb 
to the oral mucosa and the tooth pellicle (MANDEL, 1988). The adsorption to oral surfaces after the 
application is followed by progressive desorption over time. This means that CHX can move from teeth, 
mucosa, saliva, etc. to the bacterial cells. This ultimately induces bacteriostatic activity that leads to an 
important reduction in the bacterial load in the oral cavity over time (GREENSTEIN et al., 1986). This 
persistent bacteriostatic activity of CHX lasts in excess for at least 24 h (high substantivity) 
(BONESVOLL et al., 1974a; TOMÁS et al., 2010; REDA et al., 2020). 
Several methods have been used to investigate the long retention of CHX in the oral cavity after 
rinsing. At first, direct ultraviolet spectroscopy approach was used for intraoral CHX determination 
(RÖLLA et al., 1970; JENSEN et al., 1971). The method was, however, unspecific for CHX 
quantification because of the distribution by several salivary components. These components absorb 
within the same wavelength region as CHX (FIORENTINO et al., 2010). Therefore, techniques based 
on radiolabelling with carbon-14 or fluorometric method were subsequently used. Due to the higher 
sensitivity, 14C-labelled CHX could be detected in saliva 24 h after CHX application (BONESVOLL et 
al., 1974a). However, this method is ethically inapplicable to humans. Fluorometric methods were 
limited to determine CHX in aqueous solutions and centrifuged saliva (DE VRIES et al., 1991), but did 
not work in whole saliva samples and failed to reliably determine very low or high CHX concentrations 
(TSUCHIYA et al., 1999). Different approaches of high-performance liquid chromatography (HPLC) 
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have been developed for CHX determination (LAM et al., 1993; MEDLICOTT et al., 1994; PESONEM 
et al., 1995; TSUCHIYA et al., 1999). Solid-phase microextraction (SPME) was used also to monitor 
free and total concentrations of CHX in pharmacokinetic investigations (MUSTEATA, PAWLISZYN, 
2005). Although HPLC and SPME based methods are sensitive and specific for CHX determination, 
they generally need extremely long analysis times for multiple extraction and cleaning steps 
(FIORENTINO et al., 2010). Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) 
mass spectrometry (MS) was also used to determine CHX retention in microtome slices of a microbial 
contaminated wound model which was rinsed with CHX solution (HAMERLY et al., 2015).  
In MALDI-TOF analysis, the sample is first co-crystallized with a large molar excess of a matrix 
component. Then, laser radiation of this sample–matrix composition leads to the vaporization of the 
matrix which takes the analyte with it. The ionization of the analyte occurs through proton transfer from 
the matrix or cationization. All of the ions are given the same amount of energy and are accelerated to 
a detector. The ions reach the detector at different times because they have different masses. The smaller 
ions reach the detector first because of their smaller mass, which allows for greater velocity, while the 
bigger ions take longer due to their bigger mass and smaller velocity (LEWIS et al., 2000). The impacts 
of the ions on the detector are turned into electrical signals and are stored. A MS-peak is made up of a 
set of data points recorded from the detector. The highest of the peak represents the intensity of the ions 
at the detector (which had reached the detector), which in turn presents a quantity of the cretin substance 
in the sample of interest (examined sample) (KEMPKA et al., 2005). In this way, quantification of a 
substance can be done, depending on the calibration curve from the control condition with defined 
amounts of the substance (HAMERLY et al., 2015). Measurements can also be done from a conventional 
internal standard method, in which a known amount of an isotopically labelled analogue of an element 
is mixed with the investigated sample (STOCKLIN et al., 1997; STOCKLIN et al., 2000). 
The substantivity feature allows CHX to work in a way of a slow-release system. This feature leads 
to continuous, rather than an intermittent, antimicrobial activity that can prevent microbial reproduction 
(MANDEL, 1988). This property of substantivity gives CHX its advantage over many other agents and 
makes it the "gold standard" in oral antiseptics (JONES, 1997). 
2.1.4.4 Chlorhexidine pharmaceutical formulations 
The gold standard CHX has been delivered in different formulations and vehicles, such as mouth rinses, 
sprays, toothpastes, gels, varnishes, and slow-release vehicles (SHAH et al., 2019). Solutions with 
alcohol or alcohol-free 0.2% CHX have been largely recommended in Europe as a mouth rinse in 10 ml 
volumes (20 mg dose) (KENDALL, 2002). Later, in the USA, a 0.12% mouth rinse was manufactured. 
This product was recommended in 15 ml solution volumes (18 mg dose) to have almost the same dose 
derived from 10 ml of 0.2% solutions (GAGE, PICKETT, 2002). The efficacy of the two concentrations 
was evaluated in a systematic review (BERCHIER et al., 2010). Regarding the biofilm inhibition, the 
review reported a slight but significant difference in favour of the 0.2% CHX solution. However, in the 
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clinical aspect, both CHX concentrations are able to reduce gingivitis to the same extent. Alcohol-free 
CHX rinses have become also available in the market. Such formulations have been shown to have equal 
effects against biofilm formation, gingivitis, and have a better taste when compared to alcohol-
containing CHX rinses (VAN STRYDONCK et al., 2005; PAPAIOANNOU et al., 2016). 
Spray approach was used for applying a small dose of CHX (approximately 3 mg) directly to tooth 
surfaces. The CHX spray showed valuable biofilm inhibition properties (KALAGA et al., 1989a). This 
approach seems to be especially useful for the physically and mentally handicapped groups, due to its 
accessibility by individuals and their carers (FRANCIS et al., 1987 a, b; KALAGA et al., 1989 b; 
VIANA et al., 2014).  
CHX varnish has also beneficial effects on patients with chronic gingivitis. It reduces biofilm 
accumulation, bleeding levels, and also gingival scores (PUIG-SILLA et al., 2008; SACHDEVA et al., 
2018). 
CHX chips, as slow-release vehicles, have been applied as an adjunct to scaling and root planning. 
A degradable gelatine chip (PerioChip) containing 2.5 mg CHX has been commercially produced and 
evaluated in several studies with moderate periodontitis. There was significantly greater pocket depth 
reduction in the treated sites with the chips, in comparison with the sites receiving only mechanical 
treatment (SOSKOLNE et al., 1997; JEFFCOAT et al., 1998; RAJ et al. 2017; CHACKARTCHI et al., 
2019).  
In the last few years, the idea to incorporate CHX in a dental paste formulation emerged since most 
patients use a dental paste daily. With such a combination, the patient will have several advantages 
which are the following: mechanical cleaning with fluoride delivery, anti-biofilm effect, anti-gingivitis 
effect, and reduced CHX side effects with no added discomfort for patients (FIORILLO, 2019). 
Nevertheless, CHX was hardly formulated into toothpaste because of the interaction and inactivation 
between CHX particles as a dicationic antiseptic and toothpaste components, such as anionic detergent 
and calcium ions (ADDY et al., 1989; BARKVOLL et al., 1989). This explains the conclusions of two 
systematic reviews (SLOT et al., 2014; SUPRANOTO et al., 2015), where it was stated that using 
toothpaste with CHX is efficacious in the management of dental biofilm and gingivitis to some extent, 
but not to the same degree as a CHX rinsing. Furthermore, it was stated that the concentration of CHX 
inside the toothpaste should be more than 0.6% to have an anti-biofilm effect. Worth to mention that 
using CHX toothpaste induced significantly less tooth discoloration than after rinsing with CHX 
solutions (SUPRANOTO et al., 2015). 
2.1.4.5 Optimizing the use of chlorhexidine 
CHX molecule has a tendency to react with anionic surfactants (ADDY et al., 1989). To avoid any 
reduction of CHX activity, this tendency should be considered during the formulation of different CHX 
mouthwashes, spray, toothpastes, etc. (ADDY, 1986). Similarly, the interaction between CHX and 
toothpaste materials, from tooth brushing, can reduce the delivery of CHX inside the oral cavity in an 
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active form. Consequently, CHX should not be used nearly before or directly after using daily 
toothpaste. It was shown in a systematic review (KOLAHI, SOOLARI, 2006) that the best interval 
between using toothpaste and CHX application should be more than 30 min, advisedly for 2 h. 
2.1.4.6 Clinical uses of Chlorhexidine 
According to the high antimicrobial properties of CHX, a number of clinical uses have been 
recommended:  
1) As an adjunct to oral hygiene and professional prophylaxis: CHX increases the improvement of 
gingival health through biofilm control, particularly following professional prophylaxis (ADDY, 
MORAN, 2008). Indeed, as the first research demonstrated, patients could maintain almost zero levels 
of biofilm with a CHX mouth rinse, without the use of any additional mechanical oral hygiene (LÖE, 
SCHOITT, 1970). Additionally, several clinical studies showed that CHX rinsing reduces plaque 
formation and gingivitis (FAVERI et al., 2006; VAN STRYDONCK et al., 2012; AHMAD, 2020). 
Furthermore, CHX mouth rinses may be of value in maintaining oral hygiene after scaling and root 
planning; this is because adequate tooth brushing may be compromised by post-treatment soreness or 
sensitivity (BEISWANGER et al., 1992). 
2) Prophylactic pre-operative CHX rinsing and irrigation: Such pre-operative rinsing clearly reduces the 
microbial contamination of the surgical region, operator, and crew (WORRAL et al., 1987). 
Additionally, CHX rinsing reduces the occurrence of bacteraemia in treated patients (MACFARLANE 
et al., 1984). 
3) Secondary prevention after oral surgical procedures and periodontal therapy: CHX reduces bacterial 
adhesion and prevents biofilm formation. As a result, it can be used post-operatively at a time and in 
areas where mechanical cleaning may be difficult, due to discomfort. CHX can be used until the patient 
can re-establish normal oral hygiene (SANZ et al., 1989; OLSSON et al., 2012). Furthermore, it was 
shown that CHX is able to reduce bacteraemia after tooth extraction (ARTEAGOITIA et al., 2018). 
4) As a part of the oral hygiene procedures in the mentally and physically handicapped: CHX was 
successfully used to improve both gingival health and oral hygiene level in institutionalized physically 
and mentally handicapped groups (STORHAUG, 1977). Notably, the CHX spray was found to be useful 
and acceptable to patients and care workers (FRANCIS et al., 1987a, b; KALAGA et al., 1989b).  
5) Medically compromised individuals subjected to oral infections: The application of CHX, in 
combination with anti-candida drugs, have been found to be very effective in preventing oral and 
systemic infections in the immune-compromised patients receiving chemotherapy and/or radiotherapy 
procedures (FERRETTI et al., 1987). Furthermore, it was shown that CHX is able to improve the oral 
hygiene level of patients with respiratory ventilation device and hospitalized in intensive care units 
(MIRZAKHANI et al., 2017). 
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6) High-risk caries patients: It was reported that CHX rinse or gel application has a good benefit in caries 
patients due to the significant reduction of Streptococcus mutans counts in the oral cavity (LINDQUIST 
et al., 1989; COELHO et al., 2017). Additionally, a combination of CHX and sodium fluoride in one 
rinsing solution seems to be useful to such patients (DOLLES, GJERMO, 1980).  
7) Recurrent oral ulceration: It was seen in several studies that CHX, as a rinse or gel, reduces the 
incidence, duration, and severity of aphthous ulceration. This is due to the reduction in secondary 
contamination of ulcers when reducing the oral bacteria counts after application (ADDY et al., 1976; 
HUNTER, ADDY, 1987). 
8) Removable and fixed orthodontic appliance wearers: CHX has great benefits for biofilm control, 
especially when the oral hygiene is compromised at the early stages of orthodontic therapy (STIRRUPS 
et al., 1981). It was shown also in a systematic review that using CHX varnish is efficient in caries 
reduction in the course of fixed orthodontic therapy (OKADA et al., 2016). 
2.1.4.7 Toxicity, safety, and side effects of chlorhexidine 
As a result of the CHX cationic nature, it cannot be absorbed through the skin or mucosal membrane, 
including the gastrointestinal tract, which eliminates the systemic toxicity from topical application or 
ingestion (ADDY, MORAN, 2008). Unfortunately, in spite of the positive antibacterial features, several 
clinical applications, and low systemic toxicity, there are some reversible local side effects from CHX 
usage. Side effects include the following: staining of teeth, fillings, and the tongue, increased formation 
of supragingival calculus, reduced taste sensation, and seldom mucosal membrane irritation. These side 
effects always prevent the prolonged use of CHX mouth rinse (FLOTRA et al., 1972; KOUR, KAUR, 
2019). Furthermore, allergic reactions have been reported after the application of CHX in few clinical 
cases (EGNER et al., 2017). Because of these negative aspects concerning CHX application, it was 
always the trend to search for an alternative antiseptic agent with the following: similar antimicrobial 
spectrum, fewer adverse effects, and less toxicity and allergic reaction. One option is octenidine 
dihydrochloride. It has a similar antimicrobial spectrum, assumed to have fewer side effects and less 
toxicity. The reduced side effect by this agent is theoretically due to octenidine’s similar activity to 
CHX, but at a lower concentration (HUBNER et al., 2010). 
2.1.5 Octenidine 
2.1.5.1 Overview 
Octenidine dihydrochloride (OCT: C36H64Cl2N4), a bispyridine antimicrobial compound, was 
discovered in the 1980s at the Sterling-Winthrop Research Centre. It was developed as a possible local 
antibacterial product with broad-range activity, covering Gram-positive and Gram-negative bacteria, 
fungi, and several viral species (SLEE, O'CONNOR, 1983; BAILEY et al., 1984; SEDLOCK, BAILEY, 
1985). Chemically, OCT has two cationic active centres, which are separated by a long aliphatic 
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hydrocarbon chain. Therefore, it adsorbs to negatively charged surfaces, such as bacterial cell 
membranes and eukaryotic cell walls (ASSADIAN, 2016).  
It was shown in the in vitro studies that OCT has an evident antibacterial property (SLEE, 
O'CONNOR, 1983). Using suspension tests, it was found that the minimum bactericidal concentrations 
(MBCs) of OCT are ranging from 1 μg/ml to 32 μg/ml, depending on the bacterial species. There was a 
rapid antibacterial activity even after only one-minute application of OCT against the following: 
Staphylococcus epidermidis, Streptococcus pyogenes, Staphylococcus aureus, Escherichia coli, Proteus 
mirabilis, Klebsiella pneumoniae, Pseudomonas aeruginosa and Candida albicans, even in the 
existence of blood or wound exudate (PITTEN et al., 2003).  
The early animal studies on monkeys showed that 1% OCT was able to reduce plaque scores 
significantly better than 1% CHX, after 7 days of application (EMILSON et al., 1981). Also, in another 
study, OCT dentifrice was also able to prevent dental biofilm formation and, concomitantly, inhibit the 
development of gingivitis in the monkey model over the 21-days experimental period (SLEE et al., 
1985). Patters and co-workers used an experimental human gingivitis model to evaluate OCT efficacy 
in two studies. It was proved in the first one that 0.1% OCT rinsing was almost able to completely inhibit 
plaque formation. OCT with the concentration 0.05% was less effective than 0.1%, but still significantly 
better than the placebo. Additionally, gingival fluid in the OCT groups was clearly less than the control 
group. However, some tooth staining was observed also in all OCT groups (PATTERS et al., 1983). In 
the second study, there were two test groups; one test group with two-times rinsing per day and the 
second test group with three-times rinsing per day, for 21 days. Both OCT groups had almost 90% less 
plaque and 68% less gingivitis than the control group. There was no significant difference between the 
two OCT groups. Slight external tooth staining was noticed in 62% of the volunteers after rinsing with 
OCT, but it was removed by a single tooth cleaning in 90% of the conditions (PATTERS et al., 1986). 
2.1.5.2 Octenidine mode of action 
OCT exerts this particular antimicrobial effect due to its cationic charge. It binds readily to the 
negatively charged microbial cell wall. On attachment, OCT interacts with the polysaccharides in the 
cell membrane and alters the enzymatic systems there. Furthermore, it alters bacterial membrane 
permeability, which contributes to its lyses and leakage of the cytoplasm components (KRAMER, 
ASSADIAN, 2013). As a result, the microcellular metabolism is also disturbed, which disrupts and 
destroys cell functions, leading to apoptosis, programmed cell death (HARKE, 1989; GHANNOUM et 
al., 1990). Until now, bacterial resistance to OCT has not been seen in vitro. According to this fact and 
to the high concentrations used clinically, microbial resistance is not expected also in vivo 
(MCDONNELL, RUSSELL, 1999). 
2.1.5.3 Octenidine substantivity  
Since OCT binds readily to the negatively charged areas, including fibroblasts, human epithelial cells, 
and primary keratinocytes and is not absorbed through the mucosal membrane, at least part of the used 
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agent stays on the place of application and cannot be removed easily (e.g. by washing); thus, resulting 
in a depot effect that exerts a persistent antimicrobial effect (MÜLLER, KRAMER, 2007).  
This substantive bacteriostatic effect is a very important aspect of being an efficient antiseptic 
product because it is not only important to have direct antibacterial activity, but also to possess a 
continuous therapeutic effect for a period of time after the application. It was stated in previous studies 
that OCT solution has a more persistent antibacterial and anti-adhesive efficacy in compression with 
CHX and essential oil (DECKER et al., 2003; WELK et al., 2016). 
2.1.5.4 Clinical uses of octenidine 
Due to the particular antibacterial activity of OCT and its persistent effect in the oral cavity, a number 
of clinical uses have been described:  
1) As a part of oral hygiene procedures after periodontal therapy: It was shown clinically that 0.1% OCT 
application significantly reduced plaque scores and gingivitis in comparison with the placebo 
(BEISWANGER et al., 1990). 
2) High-risk caries patients: It was reported that OCT solution is effective against the cariogenic 
microorganisms (Streptococcus mutans, Lactobacillus acidophilus, Lactobacillus rhamnosus, and 
Actinomyces viscosus) even at low concentrations (CELIK et al., 2016). 
3) For endodontic irrigation: OCT can be used as endodontic irrigate due to its antibacterial efficacy and 
lower cytotoxicity. OCT was more active than 5.25% NaOCl solution as an antimicrobial endodontic 
irrigate. OCT with a concentration of 0.5% eliminated all the tested microorganisms (Staphylococcus 
aureus, Enterococcus faecalis, and Candida albicans) in only 15 seconds, where it took NaOCl 20 min 
to do the same (TIRALI et al., 2009). Additionally, 0.1% OCT was more effective as a root canal irrigant 
than 2% CHX (CHERIAN et al., 2016). Similarly, OCT was more active against Enterococcus Faecalis 
in vitro in comparison with 1% CHX and 3% NaOCl (MAKKAR et al., 2015). Also, such a result was 
found in a recent study evaluating the effect of different irrigants against Staphylococcus epidermidis 
(CHUM et al., 2019). OCT showed also an antibacterial activity against Enterococcus faecalis in the 
root canal and dentine after 1 min incubation. More effective dentine disinfection was seen after 
incubation in OCT for 10 min and 7 days (TANDJUNG et al., 2007).  
4) Treatment of chronic ulcers: It was shown that treating chronic ulcers in 43 patients with OCT 
reduced signs of inflammation and clearly improved granulation without negative effects on the wound 
recovery (VANSCHEIDT et al., 2005). 
2.1.5.5 Toxicology, safety, and side effects of octenidine 
Systemic side effects are not expected because OCT is virtually not absorbed via the mucosal membrane 
(HUBNER et al., 2010). Furthermore, OCT has a good affinity towards cardiolipin, a prominent lipid 
in the microbial cell wall. In this way, OCT causes selective harmful implications to bacterial cell 
membrane without negatively affecting human epithelium or mucosal cells (BRILL et al., 2006). 
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In vitro experiment that investigated the biocompatibility and related cytotoxicity of OCT has found 
that this substance is more toxic (i.e. effective) to both the test microorganisms (Escherichia coli and 
Staphylococcus aureus) than to murine fibroblasts with biocompatibility index (the ratio of fibroblast 
cytotoxicity to E. coli or S. aureus toxicity) greater than one. This index was less than one by CHX, 
povidone-iodine solution and ointment, silver compounds, and triclosan (MÜLLER, KRAMER, 2008). 
Similarly, a recent study has found that OCT has a lower cell-toxic effect against fibroblasts and 
epithelial cells when compared with CHX (SCHMIDT et al., 2016). 
However, the long usage of OCT mouth rinse produces a level of dental stain which needs longer 
time for dental cleaning (BEISWANGER et al., 1990). It is important to mention that more dramatic 
complications have been reported in several situations, such as after irrigation of penetrating hand 
wounds. Such irrigation can lead to chronic inflammation and aseptic tissue necrosis that persists for 
weeks or even months (LACHAPELLE, 2014). The same side effects happened after using a 
combination based on OCT and phenoxyethanol for peritoneal and bladder irrigation, as well as 
tympanic membrane washing (HULSEMANN, HABENICHT, 2009). Similarly, OCT should not be 
applied for joint irrigation, even at low concentrations such as 0.005% because it could induce a toxic 
alteration to the cartilage (MÜLLER, KRAMER, 2005).  
To avoid such dramatic complications, OCT is contraindicated to be used in deep penetrating 
wounds. Moreover, OCT must not be injected or applied with pressure to tissue cavities such as 
peritoneal, bladder, and joint cartilage if free outflow and drain-off are not ensured (HUBNER et al., 
2010). 
2.1.6 Comparison between chlorhexidine and octenidine 
Interestingly, concerning the antibacterial effect, OCT is 3 to 4 times more effective than CHX 
depending on the bacterial spices (KRAMER, ASSADIAN, 2013). For example, Celik and co-workers 
found that OCT was more effective than CHX at lower concentrations against the cariogenic 
microorganisms (Streptococcus mutans, Lactobacillus acidophilus, Lactobacillus rhamnosus, and 
Actinomyces viscosus) (CELIK et al., 2016). It was found also in vitro that OCT stays quite effective 
even when highly diluted. Whereas, CHX lost its antibacterial activity when diluted to less than 10% of 
its first concentration (ROHRER et al., 2010). In another in vitro study, all concentrations of OCT 
(0.025%, 0.05%, and 0.1%) were effective against Candida albicans and Enterococcus faecalis. 
Additionally, the inhibition zones observed by CHX with both concentrations 2% and 1% were 
significantly less than the inhibition zones induced with NaOCl and OCT (TIRALI et al., 2013). 
Similarly, 0.1% OCT was more efficient than 0.2% CHX in reducing the microbial counts 
(Enterococcus faecalis and Staphylococcus aureus) in vitro (MALHOTRA et al., 2016). 
As shown in the previously published studies and with regard to minimum inhibitory concentration 
(MIC) and MBC of OCT and CHX on a wide range of pathogens (Staphylococcus aureus, Enterococcus 
faecalis, Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Haemophilus 
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influenza, Clostridium perfringens, and Candida albicans), OCT seems to be a more effective 
antimicrobial agent compared with CHX (KOBURGER et al., 2010; LANGNER et al., 2019). 
Nevertheless, there is a lack of information concerning the anti-biofilm and biofilm disruption effects 
of each antiseptic agent, CHX and OCT, and especially the comparison between them under real in situ 
conditions. Thus, further research was necessary to fill the gaps of information concerning these two 
oral antiseptics. 
Introduction 
- 21 - 
 
2.2 Aim of this work 
Direct proof is missing, until now, about chlorhexidine (CHX) retention on mucosal surfaces and dental 
pellicle after oral CHX application. In this context, MALDI-TOF provides rational mass resolving 
power, high mass precision, high sensitivity, and can be performed in high throughput quantifications. 
These features make this method a promising technique for the determination of CHX retention in 
samples from different locations in the oral cavity and not only in saliva like done before in other studies 
(FIORENTINO et al., 2010). Such retention data should provide more information about the behaviour 
and the pharmacokinetics of CHX, especially after the application of different medical formulations. 
Additionally, previous studies have established that CHX and octenidine (OCT) are effective in 
preventing and controlling biofilm formation and consequently inhibiting and reducing the development 
of oral diseases (JONES, 1997; VAN STRYDONCK et al., 2012; ASSADIAN, 2016; WELK et al., 
2016). However, up to now, the CHX activity has been only investigated on dental biofilms growing 
on glass specimens or plastic films (AUSCHILL et al., 2005; BRECX, THEILADE, 1984) which not 
necessarily reflects what is happening on biofilms that develop directly on real enamel surfaces inside 
the oral cavity. Likewise, the anti-biofilm and the biofilm disruption effects of OCT have not been 
studied yet especially in comparison with the gold standard CHX and under most natural conditions in 
situ.  
This work - based on in situ experiments - aimed to investigate the following issues in detail: 
1) The retention of CHX in different oral sites (buccal dental pellicle, interdental area, posterior 
buccal mucosa, anterior labial mucosa, and saliva) over a 24-h period. 
2) The retention of CHX in the oral cavity after using different CHX pharmaceuticals formulations 
(mouth rinse, oral spray, and toothpaste).  
3) The effects of CHX and OCT mouth rinse on dental biofilm formation, as well as on biofilm 
disruption.  
The results should provide more details about the action mechanisms behind the evident efficacy of the 
oral antiseptics CHX and OCT. 
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3 Materials and Methods 
3.1 Chlorhexidine retention studies 
These in situ studies were aimed to determine the retention of CHX in different oral locations. This 
determination was done in the first retention study after one-time rinsing with 10 ml of 0.2% CHX for 
30 s. Furthermore, the CHX quantification was performed in the second retention study after an oral 
application of different CHX pharmaceutical formulations and regimens. 
3.1.1 Studies population 
Five periodontally and systemically healthy volunteers from laboratory staff (3 males, 2 females), aged 
24-42 years, were recruited for this work. The selected subjects were currently non-smokers. They 
provided informed consent acknowledging their willingness to participate in the experiments. Exclusion 
criteria included the following: pregnancy, nursing women, antibiotic therapy within the previous three 
months, and any systemic disease (e.g., diabetes, human immunodeficiency virus/acquired 
immunodeficiency syndrome, or autoimmune diseases). An experienced dentist carried out a visual oral 
examination to assure that the subjects do not have any active dental caries, periodontal disease, 
gingivitis, or any other oral disease that potentially affecting the salivary fluid composition. The subjects 
got detailed information on how to deal with the individual splints containing the enamel surfaces. 
The study protocols and informed consent were done under the guidelines of the Declaration of 
Helsinki. The local research ethics committee of the Medical Association of Saarland, Germany, 
approved oral specimen collection protocols (proposal 231/03, 2012). 
3.1.2 Studies design  
The first retention experiment was conducted over a 24-h period and started in the morning with the 
preceding individual. Oral hygienic measures were performed 60 min before beginning the experiment. 
No further hygienic procedures were done until the end of the 24-h period of the experiment. The 
volunteers refrained from eating and drinking 60 min before each individual sampling point. Trials were 
replicated on three weeks starting at 10:00 a.m. 
One of the subjects volunteered to refrain from eating and drinking for 11 h. Samples were 
collected from this individual similarly to the other subjects, to discover the effects of beverage and 
food ingestion on the substantivity of CHX in the oral cavity.  
Samples were taken from five different oral locations: buccal dental pellicle, interdental area, 
anterior labial mucosa opposite to the labial surface of the incisors, posterior buccal mucosa opposite 
to the buccal surface of the molars, and saliva. These samples were obtained from each volunteer at 
five-time points (1 h, 3 h, 6 h, 11 h, and 24 h) after mouth rinsing with 0.2% CHX solution in 7% 
ethanol for 30 s (Saarland University Pharmacy, Homburg, Germany) at the start of the experiment.  
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The samples were collected with a disposable micro-brush with non-absorbent and non-lining 
fibres (Clogherane, Dungarvan, Waterford, Ireland). Samples were taken by scratching the specific 
surface or immersing the brush tip into the aqueous phase of centrifuged saliva. The saliva samples 
were centrifuged at 2000 g for 2 min. After sample removal from the oral cavity locations or saliva, 
brush tips were rigorously mixed with 100 µl of α-cyano-4-hydroxycinnamic acid (CHCA) matrix 
solution {10 mg/ml α-cyano-4-hydroxycinnamic acid (Sigma-Aldrich, Steinheim, Germany), 70% 
acetonitrile and 0.07% trifluoroacetic acid (VWR International GmbH, Darmstadt, Germany)} in 
individual 2 ml Eppendorf tubes, respectively. From each tube, five drops of 0.5 µl each were pipetted 
onto a polished MALDI target plate (AB Sciex, Darmstadt, Germany) by using the dried droplet 
method. The spots were then allowed to dry. 
The second retention experiment was performed over a period of 12 h to evaluate the CHX 
retention after the application of different CHX formulations. It started in the morning at 7:00 a.m. with 
the selected individual. Extensive oral hygienic procedures were done with a minimum of 60 min before 
beginning each trail. No further oral hygienic procedures were conducted until the end of the 12-h 
period of the experiment. It was referred to the volunteers to take the main food meal 5 h after the start 
of the experiment and they were allowed to consume different beverages during the time of the 
experiment.  
The CHX formulations and regimens were as follows: 10 ml of 0.2% CHX digluconate in 7% 
ethanol mouth rinse (Saarland University Pharmacy, Homburg, Germany) for 30 and 60 s, respectively; 
10 ml of 0.12% CHX digluconate in 7% ethanol mouth rinse (Saarland University Pharmacy, Homburg, 
Germany) for 30 and 60 s, respectively; 12 squirts (one squirt equal ~137 µl) from 0.2% CHX 
digluconate Spray (GlaxoSmithKline Consumer Healthcare GmbH & Co. KG, Bühl, Germany) were 
applied directly on the teeth (6 squirts at each jaw), followed by rinsing with the total squirts for 1 min 
before spitting out the rest of the solution (the CHX spray total dose was ~3.288 mg); 1 g of CURASEPT 
ADS® 712 GEL-toothpaste without sodium lauryl sulphate (Curaden Swiss GmbH, Stutensee, 
Germany), and 1 g of GUM® Paroex® gel-toothpaste with sodium lauryl sulphate (Sunstar GmbH, 
Schönau, Germany) were used with no specific instructions concerning tooth brushing technique, 
except that the volunteers should brush the teeth for 2 min with 1 g of toothpaste containing 1.2 mg 
CHX digluconate.  
After the application of different CHX digluconate formulations, 2 µl samples from whole saliva 
and buccal mucosal pellicle, as well as dental pellicle sample, were taken. The buccal mucosa sample 
was taken from a collected mucosal pellicle after scraping the mucosal area with a plastic spatula (Carl 
Roth GmbH & Co. KG, Karlsruhe, Germany). The pellicle sample was formed on a round enamel 
specimen with a standard size of 11.35 mm². The enamel surface was polished (4000 grid) and fixed on 
an individual palatal splint (Fig. 1). 
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The samples of each subject were taken at six time points, (2 h, 4 h, 6 h, 8 h, 10 h, and 12 h), after 
application of different CHX formulations. After removal from the oral cavity, samples were 
individually embedded in 100 µl CHCA-matrix solutions. Dilution steps with matrix solution were 
necessary to be under the limit of quantification for CHX in the MALDI-TOF technique. From each 
diluted sample, 5 drops with 0.5 µl each were pipetted via dried-droplet method onto a polished MALDI 
target plate and allowed to dry. 
 
Fig. 1: Palatal acrylic splint with mounted specimens to form the dental pellicle samples for the retention 
experiment. Permission has been obtained to reuse an image published in the journal Clinical Oral 
Investigations (REDA et al., 2021b). 
3.1.3 Calibration curve of chlorhexidine 
A working solution of 0.1 mg/ml free base in 7% ethanol was prepared by filling up 88.81 µl from the 
stock solution of 0.2% CHX digluconate in 7% ethanol to 1000 µl with the matrix solution. This was 
directly diluted with the matrix solution in 2-fold to 1.9 x 10-7 mg/ml. Five replicate spots with 0.5 µl 
each were taken from each aliquot and spotted onto the MALDI target plate. 
3.1.4 MALDI-TOF mass spectrometry 
After laser radiation on the sample–matrix mixture, the CHX molecules become ionized and accelerated 
to a detector. The impacts of the CHX ions on the detector are turned into electrical signals and 
subsequently, a MS-peak is made. The highest of the peak represents the intensity of the ions at the 
detector which in turn represents the quantity of CHX in the sample of interest. 
In this study, the MALDI-TOF approach was done using Sciex 4800 TOF/TOF mass spectrometer 
(Concord, ON, Canada) in positive ionization reflector mode over a range of m/z 370-600. The system 
used a pulsed 200 Hz solid-state Nd: YAG-laser at a wavelength of 355 nm. The laser energy was set 
to 2300 units, source 1 voltage to 20 kV, grid voltage to 16 kV, and reflector detector voltage at 2.19 kV. 
CHX standard, (protonated monoisotopic molecule (Mi+H+)+ at m/z 505.21 and its monoisotopic decay 
product (Mi-NH3+H+)+ at m/z 488.21; the monoisotopic CHCA matrix dimer (2Mi+H)+ at m/z 379.09 
was utilized for internal mass calibration with a delay time of 600 Nano second. One single mass 
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spectrum was averaged from 20 individual spectra per spot using 25 accepted laser shots each. Mass 
tolerance was set to ± 0.1 u with a maximum outlier of 50 ppm. Accepted calibration settings were used 
to measure sample spectra with a minimum signal to noise of 20 and mass resolution (FWHM) > 8000. 
The measured monoisotopic peaks were extracted into Microsoft Excel worksheets. Their absolute 
intensities (ai) were normalized by calculating the ratio of ai and the sum of absolute intensities for all 
compounds in the investigated m/z range according to Irel, ai= ai /Σ (a). This resulted in relative intensities 
for the monoisotopic m/z 505.21 signal (=Irel 505, ai) of CHX. For one sample, five replicate measurements 
were performed using different sample spots. Their averaged relative intensities were used for 
calculating CHX concentrations via the calibration curve.  
3.1.5 Statistical analysis 
All CHX retention values were presented as mean ± standard deviation. The data were evaluated with 
GraphPad Prism 6, using Repeated Measures Two-Way ANOVA; Analysis of Variance as two factors 
were changing during the experiments. In the first retention study, the two factors were the sampling 
time and oral location. In the second retention study, the two factors were the sampling time and the 
CHX formulation. Multiple comparisons were performed with the Tukey test to find out if there are 
significant differences in CHX retention between the different oral sites. The same test was also 
conducted to see if there are any significant retention differences between every two CHX formulations. 
For all comparisons, p < 0.05 was considered statistically significant. 
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3.2 Anti-biofilm study 
The next in situ experiment was conducted to investigate the effects of CHX and OCT mouth rinses on 
the dental biofilm formation, as well as the biofilm disruption activity of these agents. 
3.2.1 Study population 
Five periodontally and systemically healthy volunteers, aged 22-36 years, were recruited (1 male, 
4 female). The selected subjects were current non-smokers. They provided informed consent 
acknowledging their willingness to participate in this experiment. The exclusion criteria in the anti-
biofilm experiment were the same criteria as the previous retention experiments. The subjects got 
detailed information on how to deal with the individual splints containing the enamel surfaces. 
The study protocols and informed consent were done under the guidelines of the Declaration of 
Helsinki. The local research ethics committee of the Medical Association of Saarland, Germany, 
approved oral specimen collection protocols (238/03, 2016).  
3.2.2 Study design 
This in situ study examined the anti- biofilm effects of CHX in two concentrations 0.1% and 0.2% as 
well as 0.1% OCT on dental biofilms formed on enamel specimens using two independent evaluation 
protocols (Fig. 2). 
For the evaluation of CHX and OCT effects on biofilm formation (Fig. 2 A), the volunteers wore 
the splint with eight enamel specimens for 48 h. The enamel surfaces were located in the left and right 
buccal areas and in the molar and premolar positions (4 specimens on each upper quadrant). Biofilm 
formation and bacterial vitality were evaluated at 24 and 48 h. For the biofilm disruption activity 
analysis (Fig. 2 B), a mature biofilm was allowed to be formed on 12 enamel slabs (6 specimens on 
each upper quadrant) during 48 h of intraoral exposure. Then, the volunteers started mouth rinses after 
the 48-h biofilm formation period. The biofilm ultrastructure and bacterial vitality were evaluated at 
48 h before and directly after rinsing, and repeated at 72 h of intraoral exposure. The mouth rinsing 
protocol was with a 10 ml solution for 30 s every 12 h. 
We asked the subjects to stop all mechanical oral hygiene procedures during the 48- or 72-h 
experimental time. Similarly, the application of any additional agent for chemical biofilm management 
was not allowed. Splints with fixed enamel surfaces were not subjected to any cleaning procedures.  
For the two protocols, after the intraoral exposure periods, the enamel surfaces were shortly rinsed 
with distilled water and processed directly for microscopic evaluation. Half of the surfaces were 
evaluated with transmission electron microscopy (TEM) analysis, the other half were evaluated with 
fluorescence microscopy (FM) analysis. After each test week, there was a 10-day washout period to 
eliminate the antibacterial effects of each antiseptic in the oral cavity and to restore the normal microbial 
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ecosystem. During these 10 days, the subjects cleaned their teeth with normal toothpaste that includes 
no antimicrobial elements, and they were also permitted to use inter-dental hygiene.  
 
Fig. 2: Experimental set-up of the biofilm formation analysis (A) and biofilm disruption analysis (B). Both 
analyses were performed by all 5 subjects. Rinsing steps were carried out for 30 s at the specific time points 
using 10 ml of the rinsing solution, 0.2% chlorhexidine (CHX), 0.1% chlorhexidine (CHX), 0.1% octenidine 
(OCT), or water as a control. (TEM) transmission electron microscopy; (FM) fluorescence microscopy after 
vital fluorescence staining. Permission has been obtained to reuse an image published in the journal Clinical 
Oral Investigations (MARTÍNEZ-HERNÁNDEZ et al., 2020). 
3.2.3 Specimens and splint preparation 
Enamel specimens were prepared from the labial surfaces of bovine incisor teeth. Crowns of the freshly 
extracted cattle teeth were separated from the root at the cementum-enamel junction using a diamond 
cutting disc (Schott Diamantwerkzeuge GmbH, Stadtoldendorf, Germany) along with water cooling. 
The cutting disc was fixed to a saw machine (Conrad Apparatebau Clausthal GmbH, Clausthal-
Zellerfeld, Germany). From each crown, round enamel specimens with a surface area size of 11.35 mm² 
were prepared for the second retention experiment. Further square specimens with a size of 4 x 4 mm² 
for FM analysis and 3 x 3 mm² for TEM evaluation were cut from the middle part of labial surfaces in 
order to standardize the enamel specimens. 
The enamel surfaces were polished under continuing water cooling by a polishing machine 
(Buehler, Düsseldorf, Germany), using silicon carbide grinding paper (125 to 4000 grit, FEPA-P, 
waterproof silicon carbide paper, Buehler, Düsseldorf, Germany). Then, specimens were stored in 0.1% 
thymol solution (Saarland University Pharmacy, Homburg, Germany) at 4 °C.  
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The polished enamel specimens should be cleaned before using them in the oral cavity. According 
to a previously used protocol (HANNIG et al., 2005), the enamel surfaces were first washed using a 3% 
NaOCl (Hedinger, Stuttgart, Germany) solution for 3 min to eliminate any rest from the polishing step. 
Next, they were cleaned five times in distilled water (B. Braun Melsungen, Melsungen, Germany). 
Then, a second cleansing step was conducted for a 5-min ultrasonication (Sonorex, Bandelin, 
Germany). It was followed by disinfection in 70% isopropanol (Hedinger, Stuttgart, Germany) for 
15 min, and then the cleaning was finished with another five washes in distilled water. In the end, and 
before intraoral exposure, rehydration of enamel surfaces was done by putting them in distilled water 
for at least 6 h. 
Alginate impressions (Blueprint cremix®, Dentsply DeTrey, Konstanz, Germany) were made from 
the upper and lower jaws of the subjects to produce an elastic mould. Using this mould, a hard plaster 
model was made. Transparent custom made acrylic splints (Thermoforming foils®, Erkodent, 
Pfalzgrafenweiler, Germany) were made on the plaster model as a carrier of the enamel specimens. 
These splints were designed to cover the palatal area for the retention experiment (Fig. 1) and to cover 
the molar and premolar teeth on the left and right upper jaw in the anti-biofilm studies (Fig. 3). 
In order to better stabilize the mounted specimens, the splints were provided with small 
perforations. The enamel specimens were fixed to the individual acrylic splint using silicon impression 
material (president light body®, Colténe, Altstaetten, Switzerland). 
 
Fig. 3: Buccal acrylic splint with mounted specimens to form the biofilm samples for the anti-biofilm 
experiment. 
3.2.4 Vital fluorescence microscopy evaluation - LIVE/DEAD staining 
3.2.4.1 LIVE/DEAD staining definition 
Fluorescence Microscopy analysis after LIVE/DEAD staining (LDS) is performed to distinguish and 
quantify living and dead microorganisms in the bacterial biofilm. The used staining system in this study 
(LIVE/DEAD® BacLight™ Bacterial Viability kit L7012, Invitrogen by Thermo Fisher Scientific, 
Carlsbad, USA) consists of two stains: SYTO 9 the green-fluorescent nucleic acid dye and propidium 
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iodide (PI: C27H34I2N4) the red-fluorescent nucleic acid dye. These two stains vary in their spectral 
features and in their ability to inter the microbial cells. When the bacterial cell is not damaged and the 
cell membrane is intact, only the SYTO 9 will be able to enter the bacteria and be presented inside the 
cell, thus causing the bacterial fluorescent to be green. Whereas in the case of damaged bacteria with a 
compromised membrane, both stains will be able to enter the bacteria and be presented inside the cell. 
In this case, PI dye, which has a stronger affinity toward nucleic acids, will displace the SYTO 9 and 
the cells will fluoresce in red. As a final consequence of such staining, cells with an intact membrane 
will be stained green, whereas cells that are considered to be dead or damaged will be stained red. In 
the end, the percentage of bacterial adherence (coverage) and the vitality percentage can be determined. 
3.2.4.2 Staining and preparing the specimens 
After intraoral exposure, the biofilm-covered specimens were carefully detached from the splints, gently 
washed with saline and then processed for vital fluorescence staining according to the following 
protocol. Processing of the samples was carried out at room temperature in a 6-well-plate. At the start, 
the samples were covered with 10 µl of the staining solution. This solution consisted of 1 ml 0.9% NaCl 
(B. Braun Melsungen AG, Melsungen, Germany), 1 µl SYTO 9, and 1µl PI. After that, the samples 
were kept in darkness for 15 min, and then they were washed three times with saline solution to remove 
residues of the staining solution. Then, every specimen was fixed on a glass slide (Microscopic slides, 
VWR International GmbH, Darmstadt, Germany), 5 µl of mounting oil was applied on it, and then it 
was covered with a round cover glass (VWR International GmbH, Darmstadt, Germany) until further 
processing.  
3.2.4.3 Fluorescence microscopic examination and images evaluation 
The mounted samples were observed by a fluorescence microscope (Axio Imager 2 Microscope, Zeiss 
MicroImaging GmbH, Göttingen, Germany) in combination with the image processing software 
AxioVision 4.8 (Carl Zeiss Microimaging GmbH, Göttingen, Germany). Four representative 
randomized images per specimen were taken at a magnification of 1000-fold. The biofilm colonization 
(coverage) and biofilm vitality were evaluated by using a digital program called ImageJ (ImageJ2, 
National Institutes of Health, LOCI, University of Wisconsin, USA), which is an open-source 
micrographs analysis program for multidimensional image data evaluation with a focus on scientific 
imaging.  
To evaluate the bacterial colonization, the total area of the FM image was first measured and then 
only the selected biofilm-covered area was measured. The colonization percentage was determined by 
calculating the proportion of the selected biofilm area to the total image area. 
For the vitality percentage, both green and red channels from the microscopic image were saved 
in the grey scale and then the integrated density of both channels was measured with ImageJ. After 
calculating the total density value of both channels, the biofilm vitality percentage (the percentage of 
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the green channel density) can be easily calculated. It is essential to eliminate the background effect of 
the images by measuring only the selected area of the living bacteria in the green channel and the 
damaged bacteria in the red channel. This step is imperative in avoiding any misleading results due to 
the background integrated density. 
3.2.5 Transmission electron microscopy evaluation  
3.2.5.1 Samples preparation 
After intraoral exposure, the biofilm-covered enamel surfaces considered for TEM analysis were rinsed 
gently with sterile water and then fixed with a fixing solution for one hour at 4 ºC. The fixing solution 
consists of 1% glutaraldehyde (Serva Electrophoresis GmbH, Heidelberg, Germany) and 1% 
paraformaldehyde (Science Services, München, Germany) in 0.1 M cacodylate buffer. Then, the 
samples were washed five times with 0.1 M cacodylate buffer for 10 min each and then stored in the 
last buffer solution at 4 ºC until further processing. 
For imaging of the organic biofilm structure, specimens were post-fixed with 2% osmium tetroxide 
in cacodylate buffer for 1 h. Then, the samples were rinsed five times with distilled water and 
dehydrated in increasing concentrations of ethanol. The dehydration was done at room temperature. 
The specimens went through series of 50% (2x 10 min), 70% (2x 20 min), 90% (2x 30 min) and 100% 
(2x 30 min) ethanol. Afterward, they were further immersed in 100% acetone twice for 30 min each 
and kept overnight in an acetone/Araldite mixture (Agarscientific, Stansted, United Kingdom), 
including a 3% accelerator (mixture A) at room temperature. On the next day, mixture A was poured 
out and a second mixture, mixture B, was prepared (Araldite mixture with 2% accelerator). Specimens 
were stored again overnight in mixture B at room temperature in the air chamber. Then, a new mixture B 
was utilized to fill half of the embedding forms. Notes with identification numbers were inserted at the 
bottom part, and the embedding forms were filled until the top with mixture B, once more. Next, 
specimens were incubated for polymerization for 48 h at 65 °C. After polymerization, samples were 
decalcified in hydrogen chloride (HCl) and re-embedded in Araldite. Finally, all the samples were cut 
in ultra-thin sections (about 50-80 nm) in an ultramicrotome using a diamond knife (Leica EM UC7, 
Germany) and mounted on Pioloform-coated copper grids. Then, the samples were contrasted with 
aqueous solutions of uranyl acetate and lead citrate at room temperature. After an intensive rinse with 
distilled water, biofilm specimens are then ready to be evaluated with TEM.  
3.2.5.2 TEM analysis 
Characteristic images of the biofilm ultrastructure, under the influence of CHX and OCT rinsing or 
water rinsing (control), were performed at magnifications ranging from 2500- to 80000-fold by a TEM 
TECNAI 12 Biotwin (FEI, Eindhoven, Netherlands). For the biofilm thickness assessment, two 
representative images per specimen were evaluated at the magnifications of 11000- and 13000-fold. 
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Four measurements of the biofilm thickness (µm) at each micrograph were made by using ImageJ 
software and the average value from these measurements was taken for statistical evaluation  
3.2.6 Statistical analysis 
Statistical analysis for the comparison between the experimental groups in the anti-biofilm experiment 
was performed with GraphPad Prism 6 software package. The analysis was conducted by Repeated 
Measures One-Way ANOVA Analysis of Variance with Geisser-Greenhouse correction to control the 
violations of sphericity. One-Way ANOVA Test was followed by multiple comparisons made by the 
Tukey test to compare each test group with the other ones. 
It is noteworthy to mention that the Shapiro-Wilk Normality Test was used to investigate if the 
data follow the Gaussian distribution. Additionally, the tests for equal variances were conducted using 
the Brown-Forsythe test. Statistical significance was set at p < 0.05. 
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4 Results 
The following results were obtained through MALDI-TOF mass spectrometry, vital fluorescence 
microscopy, and TEM evaluations. The MALDI-TOF technique provided reliable detection limits for 
the determination of CHX after mouth rinsing as well as after the application of different pharmaceutical 
products. 
The evaluation of bacterial biofilm colonization and bacterial vitality using fluorescence 
microscopy approach allowed the investigation of the effect of CHX and OCT mouth rinses on the oral 
biofilm under in situ conditions. Furthermore, TEM provided the possibility to study biofilm 
ultrastructure under the effect of the aforementioned oral antiseptics. In the current experiment, not only 
the effects of CHX and OCT on the biofilm formation were evaluated, but also the biofilm disruption 
activity of CHX and OCT on the mature biofilm was investigated. 
4.1 Retention studies results 
4.1.1 Chlorhexidine calibration curve 
A reproducible calibration curve was created from a diluted sequence of CHX. This calibration curve 
in combination with the MALDI-TOF approach were used as a quantitative tool for the determination 
of CHX values in experimental samples. The CHX protonated monoisotopic molecule (Mi+H+)+ was 
detected at m/z 505.21 g/mol (Fig. 4).  
The calibration curve was linear from 1.5 x 10-3 µg/ml to 0.39 µg/ml of CHX free base with a 
regression correlation coefficient of R2 = 0.9972 (Table 1, Fig. 5). These values were the limits of 
quantification of CHX. Beyond 0.39 µg/ml, detection saturation was observed. Below 1.5 x 10-3 µg/ml, 
the predefined minimum S/N ratio of 20 prevented quantification of smaller signals (Fig. 6). After the 
determination of CHX concentration in the matrix sample mixtures, the dilution factor was applied for 
calculating the CHX concentrations in the undiluted oral samples.  
 
Fig. 4: Typical mass spectrum of chlorhexidine according to MALDI-TOF technique. 
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Table 1: The chlorhexidine (CHX) values (µg/ml) and their relative intensity (Rel. Int) where the calibration 
curve was linear. 
CHX µg/ml 0.3905 0.1953 0.0976 0.0488 0.0244 0.0122 0.0061 0.0031 0.0015 0.0008 
Rel. Int 505 0.1297 0.0702 0.0379 0.0176 0.0089 0.0028 0.0027 0.0015 0.0010 0.0000 
 
 
Fig. 5: Calibration curve of chlorhexidine (CHX) concentrations versus their relative intensity values. The 
curve ranges from 1.5 x 10-3 µg/ml to 0.39 µg/ml. The linear equation and the quadratic correlation 
coefficient are given for this range. Permission has been obtained to reuse a diagram published in the journal 
Clinical Oral Investigations (REDA et al., 2021b). 
 
 
Fig. 6: The complete calibration curve of chlorhexidine (CHX) concentrations versus their relative intensity 
values Beyond 0.39 µg/ml, detection saturation was observed. Below 1.5 x 10-3 µg/ml, the predefined 
minimum S/N ratio of 20 prevented quantification of smaller signals. 
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4.1.2 Chlorhexidine retention in different oral locations after mouth rinsing 
Possible discrepancies in CHX sampling efficacy was avoided due to the use of standardized micro-
brushes with non-absorbent fibres in their tips for sampling from different oral sites. The micro-brush 
tips did not enrich CHX after the saturation of their tip absorption capacities with salivary film covering 
the teeth (buccal or interdental area) or mucosa. This made sampling independent from the wiped area 
in oral sites and enabled comparison of CHX retention in saliva to CHX retention in different oral sites.  
The concentrations of oral CHX in different sites decreased with time after mouth rinsing (Fig. 7). 
The highest reduction in CHX-retention has happened in the first 6 h and plateaued at low 
concentrations in the oral cavity. It was even detected 24 h after application (Table 2). 
 
Fig. 7: Mean chlorhexidine (CHX) concentrations (µg/ml) in five different oral locations (dental pellicle, 
interdental area, anterior labial mucosa, posterior buccal mucosa, saliva) of five volunteers under normal 
diet during 24 h after mouth rinsing with 10 ml chlorhexidine solution (0.2%) for 30 s. Permission has been 
obtained to reuse a diagram published in the journal Archives of Oral Biology (REDA et al., 2020). 
For a normal diet, CHX retention one-hour after rinsing was higher in the dental pellicle than all 
other oral locations, with a mean concentration of 194.5 µg/ml (Fig. 8 A). The highest substantivity of 
CHX was detected in the interdental area with a mean concentration of 2.4 µg/ml, 24 h after CHX 
rinsing. Relatively high CHX retention was observed at the mucosal surfaces (Fig. 8 C and D). No 
significant difference in CHX retention between anterior labial mucosa and posterior buccal mucosa 
was seen (p = 0.89). Although, no significant differences in CHX retention between the four oral 
locations: dental pellicle, interdental area, buccal and labial mucosa were detected (p > 0.05), the CHX 
retention in saliva was significantly lower compared to the retention in the aforementioned four oral 
sites (p < 0.05) (Table 2, Fig. 8 E). 
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Table 2: Chlorhexidine retention in five different oral locations (buccal dental pellicle, interdental area, 
anterior labial mucosa, posterior buccal mucosa, and saliva) of five volunteers during 24 h after mouth 
rinsing with 10 ml chlorhexidine digluconate solution (0.2%) for 30 s. Permission has been obtained to reuse 
a table published in the journal Archives of Oral Biology (REDA et al., 2020). 












1 194.5 ± 59.1 94.9 ± 39.1 87.2 ± 59.8 81.1 ± 37.12 37.3 ± 15.2 
3 55.1 ± 37.6 65.2 ± 28.6 74.1 ± 30.2 59.2 ± 27.25 17.6 ± 9.8 
6 22.5 ± 25.5 33.7 ± 23.3 43.2 ± 25.7 32.6 ± 39.78 4.3 ± 3.1 
11 12.1 ± 16.2 18.4 ± 17.3 5.3 ± 3.9 3.7 ± 3.31 0.6 ± 0.4 
24 0.7 ± 0.4 2.4 ± 2.3 0.2 ± 0.1 0.2 ± 0.1 0.06 ± 0.03 
† Mean concentrations (µg/ml) ± Standard Deviation. 
* Chlorhexidine retention in saliva was significantly lower than the other oral locations. Statistically 
significant association (p < 0.05). 
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Fig. 8: Mean chlorhexidine (CHX) concentrations (μg/ml) ± standard deviation in five different oral 
locations (A: buccal dental pellicle, B: interdental area, C: anterior labial mucosa, D: posterior buccal 
mucosa, E: saliva) of five volunteers under normal diet during 24 h after mouth rinsing with 10 ml 
chlorhexidine digluconate solution (0.2%) for 30 s. Permission has been obtained to reuse diagrams 
published in the journal Archives of Oral Biology (REDA et al., 2020). 
The fasting volunteer displayed unorthodox results. Retention of CHX in all oral sites was higher 
in comparison to the normal diet, and CHX stayed at high concentrations during the fasting period of 
11 h in almost all oral sites. In the dental pellicle and mucosa, the CHX concentrations were 315.1 µg/ml 
and 84.2 µg/ml, respectively, 1 h after mouth rinsing, and they remained virtually the same (302.2 and 
79.8 µg/ml) for 11 h (Table 3, Fig. 9).  
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Again, the CHX retention in saliva was significantly lower compared to the retention in the other 
four oral sites (p < 0.05) (Table 3, Fig. 9). 
Table 3: Chlorhexidine concentrations (µg/ml) in five different oral locations (dental pellicle, interdental 
area, anterior labial mucosa, posterior buccal mucosa, and saliva) of the abstinent volunteer during 11 h after 
mouth rinsing with 10 ml of chlorhexidine solution (0.2%) for 30 s. 












1 315.13 93.07 84.23 100.72 28.87 
3 217.66 143.04 89.93 100.37 15.67 
6 327.01 75.39 84.00 73.2 22.85 
11 302.23 41.17 79.81 64.99 2.32 
† Mean concentrations (µg/ml). 
* Chlorhexidine retention in saliva was significantly less than the other locations. Statistically significant 
association (p < 0.05). 
 
Fig. 9: Mean chlorhexidine (CHX) concentrations (µg/ml) in five different oral locations (buccal dental 
pellicle, interdental area, anterior labial mucosa, posterior buccal mucosa, saliva) of the abstinent volunteer 
during 11 h after mouth rinsing with 10 ml chlorhexidine solution (0.2%) for 30 s.  
4.1.3 Chlorhexidine retention after application of different pharmaceutical regimens 
The concentrations of oral CHX at different sites decreased with time after the application of different 
CHX protocols (Figs. 10-12).  
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Fig. 10: The mean concentrations (µg/ml) of chlorhexidine (CHX) at the buccal mucosa over 12 h after 
application of different chlorhexidine formulations. Permission has been obtained to reuse a diagram 
published in the journal Clinical Oral Investigations (REDA et al., 2021b). 
 
Fig. 11: The mean concentrations (µg/ml) of chlorhexidine (CHX) in saliva over 12 h after application of 
different chlorhexidine formulations. Permission has been obtained to reuse a diagram published in the 
journal Clinical Oral Investigations (REDA et al., 2021b). 
 
Fig. 12: The mean retention (µg/cm²) of chlorhexidine (CHX) in the dental pellicle over 12 h after 
application of different chlorhexidine formulations. Permission has been obtained to reuse a diagram 
published in the journal Clinical Oral Investigations (REDA et al., 2021b). 
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The highest decline in CHX-concentration in the oral cavity was during the first 6 h after 
application, and then it sustained low concentrations in the oral cavity with a level of micrograms per 
millilitre for at least 12 h (Tables 4 and 5). 
Table 4: Chlorhexidine (CHX) retention of five volunteers at the buccal mucosa over 12 h after application 
of different chlorhexidine formulations. Permission has been obtained to reuse a table published in the 
journal Clinical Oral Investigations (REDA et al., 2021b). 




60 s rinse 
0.2% CHX 
30 s rinse 
0.12% CHX 
60 s rinse 
0.12% CHX 









2 284.1 ± 65.1 262.3 ± 78 232.9 ± 9.2 231.7 ± 25.7 156.1 ± 39.5 1.8 ± 1.9 2.7 ± 2.3 
4 172.3 ± 51.4 133.1 ± 42.3 127.1 ± 64.5 124.7 ± 63.6 46.3 ± 22.2 0.9 ± 0.8 0.3 ± 0.2 
 ـ ـ 20.3 ± 13.8 13.1 ± 20.7 13.1 ± 19.9 15.9 ± 24.7 23.3 ± 36.2 6
 ـ ـ 2.4 ± 3.7 6.3 ± 7.5 5.1 ± 9.7 9.1 ± 11.6 18.8 ± 33.9 8
 ـ ـ 1.9 ± 2.2 2.8 ± 4.6 3.3 ± 3.6 7.3 ± 7.2 16.3 ± 20.9 10
 ـ ـ 0.4 ± 0.4 1.8 ± 1.3 3.3 ± 1.6 1.8 ± 2.1 5.2 ± 7.3 12
† Mean concentrations (µg/ml) ± Standard Deviation. 
 chlorhexidine less than the limit of quantification = ـ
Table 5: Chlorhexidine (CHX) retention of five volunteers in saliva over 12 h after application of different 
chlorhexidine formulations. Permission has been obtained to reuse a table published in the journal Clinical 
Oral Investigations (REDA et al., 2021b). 




60 s rinse 
0.2% CHX 
30 s rinse 
0.12% CHX 
60 s rinse 
0.12% CHX 









2 17.3 ± 10.7 25.7 ± 17.7 17.2 ± 6.8 11.4 ± 5.5 7.5 ± 5.6 0.1 ± 0.1 0.1 ± 0.1 
 ـ ـ 3.9 ± 3.3 3.9 ± 5.6 8.5 ± 8.9  4.7 ± 6.8 6.8 ± 10.7 4
 ـ ـ 0.5 ± 0.6 0.3 ± 0.6 3.9 ± 3.4  1.6 ± 1.9 4.2 ± 4.6 6
 ـ ـ 0.3 ± 0.4 0.3 ± 0.47 1.5 ± 1.4  1.2 ± 1.3 2.8 ± 2.3 8
 ـ ـ 0.2 ± 0.1 0.03 ± 0.07 0.2 ± 0.4 0.6 ± 0.5 1.2 ± 1.4 10
 ـ ـ ـ 0.03 ± 0.02 0.2 ± 0.2  0.1 ± 0.2 0.6 ± 0.5 12
† Mean concentrations (µg/ml) ± Standard Deviation. 
 chlorhexidine less than the limit of quantification = ـ
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After the application of different formulations, there was significantly higher retention of CHX at 
the buccal mucosa compared with the retention in saliva (Tables 4 and 5; Fig. 13) 
 
Fig. 13: The mean concentrations (µg/ml) of chlorhexidine (CHX) at the buccal mucosa in comparison with 
saliva over 12 h after application of different chlorhexidine formulations. 
After mouth rinsing, there were relatively higher retentions of CHX in the mucosal pellicle, saliva, 
and dental pellicle when the rinse was performed either at a higher concentration or for a longer rinsing 
time. For example, 12 h after mouth rinsing there was higher substantivity in the mucosal pellicle when 
0.2% of CHX was used for 60 s (7.3 ± 5.2 µg/ml) comparing with the concentration when 0.12% CHX 
was used for 60 s (1.6 ± 3.3 µg/ml) (Table 4). Furthermore, the difference was statistically significant 
in some cases such as between 0.2% for 60 s and the 0.12 % for 60 s (p = 0.015), as well as between 
0.2% for 60 s and 0.12% for 30 s (p = 0.005). 
Similarly, both the application of higher concentration and longer rinsing time cause a more CHX 
retention in saliva and the dental pellicle (Tables 5 and 6). However, the difference between the rinsing 
protocols in these locations was not statistically significant (p = 0.49 in saliva and p = 0.16 in the 
pellicle). 
Interestingly, considerable CHX retention was detected after spray application. This retention 
lasted in the oral cavity for at least 12 h. Furthermore, there were no significant differences in CHX 
retention between the spray application and the rinsing regimens in saliva and dental pellicle except 
with 0.2% CHX rinsing for 60 s (p = 0.03, p = 0.005; respectively). However, in the buccal mucosa 
pellicle, the differences between the spray application and the four rinsing regimens were statistically 
significant. 
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In the present study, the retention of CHX changed as the dosage of the CHX in different regimens 
changes. In other words, when the dosage of the drug raised from 1.2 mg in the toothpaste to 3.28 mg 
in the spray, to 12 mg in the 0.12% mouth rinse, and 20 mg in the 0.2% mouth rinse, the mean CHX 
retention in the mucosal pellicle increased from 2.7 µg/ml after tooth brushing, to 156.1 µg/ml after 
spray application, to 232.9 µg/ml after 0.12% mouth rinse, and to 284.1 µg/ml after 0.2% CHX rinsing 
at the 2-h time point (Table 4).  
Similarly, this condition of increased retention in accordance with higher dosage at application was 
also seen in saliva and the pellicle (Tables 5 and 6). For example, as seen in Table 6, there was 
significantly lower adsorption of CHX in the dental pellicle when the toothpastes were used 
(0.01 - 0.02 µg/cm²) compared with the retention obtained when the different rinsing protocols were 
applied (0.25 - 0.33 µg/cm²) at 2-h time point. 
Table 6: Chlorhexidine (CHX) retention of five volunteers in the dental pellicle over 12 h after application 
of different chlorhexidine formulations. Permission has been obtained to reuse a table published in the 
journal Clinical Oral Investigations (REDA et al., 2021b). 




60 s rinse 
0.2% CHX 
30 s rinse 
0.12% CHX 
60 s rinse 
0.12% CHX 









2 0.33 ± 0.15 0.25 ± 0.09  0.32 ± 0.25 0.26 ± 0.15 0.15 ± 0.11 0.02 ± 0.02 0.01 ± 0.01 
4 0.28 ± 0.09 0.18 ± 0.08  0.22 ±0.17  0.18 ± 0.11  0.07 ± 0.04 0.01 ± 0.01 0.01 ± 0.01 
 ـ ـ 0.04 ± 0.05 0.08 ± 0.09 0.03 ± 0.09  0.06 ± 0.13 0.15 ± 0.21 6
 ـ ـ 0.04 ± 0.04  0.03 ± 0.05 0.04 ± 0.05  0.04 ± 0.10 0.06 ± 0.12 8
 ـ ـ 0.02 ± 0.02 0.03 ± 0.04 0.02 ± 0.03  0.04 ± 0.05 0.02 ± 0.06 10
 ـ ـ 0.02 ± 0.02 0.02 ± 0.02 0.01 ± 0.02  0.03 ± 0.04 0.01 ± 0.06 12
† Mean retention (µg/cm²) ± Standard Deviation. 
 .chlorhexidine less than the limit of quantification = ـ 
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4.2 Anti-biofilm study results 
4.2.1 Chlorhexidine and octenidine effects on biofilm formation 
To analyse the effect of CHX and OCT rinsing on in situ biofilm formation on real enamel surfaces, 
five volunteers wearing splints with attached bovine enamel specimens applied the mouth rinses with 
0.1% CHX, 0.2% CHX, 0.1% OCT, or water as a control every 12 h during a 48-h time period. At two 
time points, 24 h and 48 h, the enamel surfaces were taken and the resulting biofilms were evaluated by 
FM after staining with fluorescent dyes, which allows the bacterial vitality evaluation. Furthermore, the 
thickness and morphology of the dental biofilm were assessed by TEM (Fig. 2 A).  
4.2.1.1 FM-evaluation 
The effect of the CHX and OCT rinsing on the oral bacterial colonization was evaluated successfully 
using fluorescence microscopy at 24- and 48-h time intervals. Representative images of the bacterial 
colonization at 24 and 48 h of intraoral exposure are presented in figures 14 and 15, respectively. A 
thick biofilm containing high proportions of living microorganisms was seen on the control surfaces 
(rinsed with water) after 24 h of intraoral exposure (Fig. 14 A and B). In addition to the bacteria with 
coccoid morphology which are the most common microorganism in the oral biofilm, fibrils and rod-
shaped bacteria were also visible. In contrast, scattered microbial colonies or isolated microorganism 
were found on CHX- and OCT-rinsed specimens (Fig. 14 C-H). Rinsing with 0.2% CHX reduced the 
microbial colonization and induced a significant reduction in bacterial vitality. CHX rinsing with a 
concentration of 0.1% was also able to reduce the bacterial vitality and reduce the bacterial adhesion. 
Oral rinsing with 0.1% OCT was even more effective and able to almost completely eliminate bacterial 
colonization in comparison with the water control (Fig. 14 G and H, Fig. 16 A and B).  
In this context, the reduction in the mean values of oral bacteria colonization was from 20% in the 
control group to 1.5%, 4.5%, and 0.4% in the 0.2% CHX, 0.1% CHX, or 0.1% OCT groups, 
respectively. Similarly, the reduction in bacterial vitality decreased from 70% in the control to 4%, 
12.3%, and 1.25% in the 0.2% CHX, 0.1% CHX, and 0.1% OCT, respectively. 
After 48 h of intraoral exposure (Fig. 15), mature and multi-layered biofilm containing a high 
portion of living microorganism was seen on the control samples (Fig. 15 A and B). In contrast, a 
significant reduction in biofilm coverage with few isolated dead bacteria was observed on the 0.2% 
CHX treated surfaces (Fig. 15 C and D). Also, 0.1% CHX rinse was very effective to reduce bacterial 
adhesion and only a few bacterial colonies were seen on the enamel surfaces (Fig. 15 E and F). 
Additionally, bacterial vitality after rinsing with both CHX concentrations was significantly reduced 
(Fig. 16 D). Similarly, after rinsing with 0.1% OCT, there was a significant reduction in biofilm 
coverage and bacterial vitality when compared with water rinsing (Fig. 16 C and D). This reduction was 
similar to the 0.2% CHX effect. There was almost no bacterial adhesion on the OCT treated surfaces 
(Fig. 15 G and H).  
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The reduction in the biofilm coverage was from 63% in the control to 1.15%, 11.3%, and 0.5% in 
the 0.2%, 0.1% CHX, and 0.1% OCT groups, respectively. Furthermore, the reduction in bacterial 
vitality was from 71.5% in the control biofilms to 4.5%, 11.5%, and 1.9% in the 0.2% CHX, 0.1% 
CHX, and 0.1 %OCT groups, respectively. 
After comparing the different treatment regimens concerning the colonization and vitality, the 
results are summarized as follows: At 24-h time point, there was no significant difference between both 
concentrations of CHX and OCT regarding the biofilm coverage, whereas there was a significant 
difference between 0.1% CHX and 0.1% OCT (p = 0.0036) in regards of the biofilm vitality (Fig.16 A 
and B). Whereas, at the 48-h evaluation time point, 0.2% CHX and 0.1% OCT were more effective than 
0.1% CHX in reducing the bacterial colonization and biofilm coverage (p = 0.021, p = 0.016; 
respectively). Whereas, there was no significant difference in biofilm vitality reduction between the 
rinses at this point (Fig. 16 C and D). 
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Fig. 14: Effect of chlorhexidine (CHX) and octenidine (OCT) on biofilm formation. The figure shows 
representative fluorescence images after LIVE/DEAD staining (living bacteria are stained green and dead 
bacteria are stained red) of the 24-h biofilm formed on enamel surfaces after two times rinsing with water 
(A and B) covered with vital biofilm, as well as enamel surfaces after two times rinsing with 0.2% CHX (C 
and D), 0.1% CHX (E and F), or 0.1% OCT (G and H) covered with scattered dead bacteria. Permission has 
been obtained to reuse images published in the Journal of Dental Research (REDA et al., 2021a).  
Results 
- 45 - 
 
 
Fig. 15: Effect of chlorhexidine (CHX) and octenidine (OCT) on biofilm formation. The figure shows 
representative fluorescence images after LIVE/DEAD staining (living bacteria are stained green and dead 
bacteria are stained red) of the 48-h biofilm formed on enamel surfaces after 4 times rinsing with water (A 
and B) covered with vital mature biofilm, as well as enamel surfaces after 4 times rinsing with 0.2% CHX 
(C and D), 0.1% CHX (E and F), or 0.1% OCT (G and H) covered with scattered dead bacteria. Permission 
has been obtained to reuse images published in the Journal of Dental Research (REDA et al., 2021a). 
Results 
- 46 - 
 
  
Fig. 16: Quantification of biofilm coverage and bacterial vitality at 24 h (A and B) and 48 h (C and D). In 
comparison with water rinsing, chlorhexidine (CHX) and octenidine (OCT) rinsing solutions caused a 
significant reduction in biofilm coverage and biofilm vitality at both time-points. Analysed were 320 
independent images (160 images at each time point); min to max values are shown as floating bars and the 
middle line refers to the mean. Statistically significant association: (p < 0.05). ns: not significant. 
4.2.1.2 TEM-evaluation 
The TEM images show clear differences in the thickness and ultrastructural appearance of the biofilm 
found on the control specimens (rinsed with water) compared to the biofilm found on the test specimens 
(rinsed with CHX and OCT) at 24 and 48 h of intraoral exposure (Figs. 17-19). 
All enamel surfaces after 24 h of intraoral exposure were covered by a globular structured pellicle 
layer with adherent microorganism. The pellicle of the control specimens was covered either partly or 
entirely with a multi-layer of bacteria. The majority of the bacteria observed were cocci in addition to 
some short rod-shaped bacteria (Fig. 17 A and B). They appeared generally intact and well preserved, 
but in some cases, lysed microorganisms were also observed. In contrast, on the CHX rinsed specimens, 
the pellicle surface was, in most places, not colonized by microorganisms and when bacteria were 
attached to the surface, it was only a monolayer of microorganisms. Most of the detected 
microorganisms revealed prevalently a coagulated cytoplasm and compromised cell membrane 
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(Fig. 17 C-F). Also, some lysed bacteria (cell ghosts) were found (Fig. 17 C). In agreement with the 
FM images, no bacterial colonization was seen on the test surfaces rinsed with 0.1% OCT. The 
specimens were covered only by a dental pellicle layer (Fig. 17 G and H). 
The thickness of the pellicle layer and microbial deposits varied between the control and test 
specimens (Fig. 20 A). On the specimens rinsed with water, a biofilm with a thickness of 
3.617 ± 1.735 µm was observed covering the surfaces. Whereas the biofilm thickness significantly 
decreased after rinsing with the test solutions at 24 h of intraoral exposure evaluation. This thickness 
was (1.15 ± 0.18 µm) by using 0.2% CHX, (0.50 ± 0.26 µm) by using 0.1% CHX, and (0.73 ± 0.11) in 
case of 0.1% OCT. There was a statistically significant difference between the control and treated 
surfaces concerning biofilm thickness, whereas there was no significant difference between the rinsing 
protocols (Fig. 20 A). 
After 48 h of intraoral exposure (Figs. 18 and 19), it was observed that a pellicle layer covered all 
specimens. On the control surfaces, (Fig. 18 A-D) a multilayer biofilm was observed coating the surface 
of the specimens. The majority of the microorganisms appeared generally intact and well preserved. 
Furthermore, some of them were trying to multiply (Fig. 18 D). Whereas on the CHX treated specimen, 
(Fig. 18 E–H, Fig. 19 A and B) a pellicle layer was observed covering these surfaces with some 
microorganisms. These bacteria were seen prevalently damaged with a coagulated cytoplasm. 
Furthermore, some lysed bacteria were found (cell ghosts) (Fig. 18 G). Again, in the 48 h evaluation 
point, no bacterial adhesion was detected on the treated surfaces with 0.1% OCT (Fig. 19 C and D). 
The biofilm thickness on the test surfaces was significantly reduced (p < 0.0001) in comparison 
with the thickness on control specimens (Fig. 20 B). The biofilm thickness was 1.49 ± 0.44 µm on 0.2% 
CHX treated surfaces, 1.37 ± 0.29 on 0.1% CHX treated surfaces and 0.54 ± 0.09 on 0.1% OCT treated 
surfaces vs. 12.32 ± 6.58 µm in control surfaces. 
According to the TEM analysis, there were significant differences between the biofilm found on 
the control specimens and the biofilm on the treated specimens with CHX or OCT regarding the 
thickness and ultrastructural appearance. These differences were found at both evaluation time points, 
after 24 and 48 h in situ. Whereas, there were no significant differences between the oral rinses 
regarding the biofilm thickness at both time points (Fig. 20). The TEM results are in good agreement 
with the FM findings observed in the present study and underline the evident anti-biofilm potential of 
CHX and OCT solutions under most natural conditions in situ. 
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Fig. 17: Effect of chlorhexidine (CHX) and octenidine (OCT) on 24-h biofilm formation. The figure shows 
representative TEM micrographs of the 24-h biofilm formed on enamel surfaces after 2-times rinsing with 
water (A and B) covered with multi-layered vital biofilm, as well as TEM micrographs of enamel surfaces 
after 2-times rinsing with 0.2% CHX (C and D) and 0.1% CHX (E and F) covered with mono-layered biofilm 
with damaged bacteria. The figure shows also that there was no bacterial coverage on the surfaces after 
rinsing with 0.1% OCT (G and H). * Previous enamel surface. Permission has been obtained to reuse images 
published in the Journal of Dental Research (REDA et al., 2021a). 
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Fig. 18: Effect of 0.2% chlorhexidine (CHX) on 48-h biofilm formation. The figure shows representative 
TEM micrographs of the 48-h biofilm formed on enamel surfaces after 4-times rinsing with water (A-D) 
covered with multi-layered vital biofilm, as well as TEM micrographs of enamel surfaces after 4-times 
rinsing with 0.2% CHX (E-H) covered with mono-layered biofilm with damaged bacteria (cell ghosts). 
* Previous enamel surface. Permission has been obtained to reuse images published in the journal Clinical 
Oral Investigations and Journal of Dental Research (MARTÍNEZ-HERNÁNDEZ et al., 2020; REDA et al., 
2021a). 
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Fig. 19: Effect of 0.1% chlorhexidine (CHX) and 0.1% octenidine (OCT) on 48-h biofilm formation. 
Representative TEM micrographs of the 48-h biofilm formed on enamel surfaces after 4-times rinsing with 
0.1% CHX (A and B), or 0.1% OCT (C and D) without any bacterial coverage. * Previous enamel surface. 
Permission has been obtained to reuse images published in the Journal of Dental Research (REDA et al., 
2021a). 
 
Fig. 20: Quantification of biofilm thickness at 24 h (A) and 48 h (B). In comparison with water rinsing, 
chlorhexidine (CHX) and octenidine (OCT) rinsing solutions caused a significant reduction in the biofilm 
thickness at both time points. Mean values from analyses of 80 micrographs (40 at each time point) are 
shown. Min to max values are shown as floating bars and the middle line refers to the mean. Statistically 
significant association: (p < 0.05). ns: not significant.  
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4.2.2 Chlorhexidine and octenidine disruption effect on mature biofilm  
The disruption potential of CHX and OCT on preformed mature biofilm was evaluated by two times 
application of mouth rinse on a 48-h biofilm over a period of 24 h and a total of 72 h intraoral exposure. 
Again, the evaluation was performed by using FM and TEM approaches. 
4.2.2.1 FM-evaluation 
The disruption effect of CHX and OCT rinses on the existent mature biofilm assessed by FM can be 
seen in figures 21 and 22. Before the rinsing (at 48 h of intraoral exposure), matured, dense, and multi-
layered biofilms were seen covering the entire specimen of the control surfaces (Fig. 21 A and B). 
Microorganisms were identified as having a coccoid, and rod-shaped form. In contrast, a significant 
shift to lower vitality was observed in the 48-h biofilm after the first CHX or OCT application 
(Fig. 21 C-H). Rinsing with 0.2% CHX and 0.1% OCT solutions were able to disrupt the multi-layered 
mature biofilm. Furthermore, a statistically significant reduction in the biofilm coverage was detected 
and some parts of the enamel specimens were clean without any bacterial accumulation especially after 
the second rinsing (Fig. 22 C-D, Fig. 22 G-H). However, the 0.1% CHX was effective in biofilm 
disruption, but less than the 0.2% CHX or 0.1% OCT rinses. It is clear in the FM evaluation (Fig. 21 E 
and F, Fig. 22 E and F) that even though the specimens treated with 0.1% CHX are fully covered with 
bacteria, but the maturity and the complexity of the biofilm were less dominant. 
After the statistical analysis and comparing the different treatment regimens, it is important to note 
that the higher concentration of CHX (0.2%) was significantly more active in reducing the bacterial 
vitality and biofilm coverage than 0.1% CHX. Moreover, according to the fluorescence images, 0.2% 
CHX had the most disruptive activity against the 48-h mature biofilm especially after the second rinsing 
(Fig. 22 C and D). However, there was no significant difference between 0.2% CHX and 0.1% OCT in 
both the vitality and coverage parameters (Fig. 23). Thus, rinses with 0.2% CHX and 0.1% OCT have 
great biofilm disruptive potential. 
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Fig. 21: Effect of chlorhexidine (CHX) and octendine (OCT) on biofilm disruption. The figure shows 
representative fluorescence images after LIVE/DEAD staining (living bacteria are stained green and dead 
bacteria are stained red) of the 48 h-biofilm formed on enamel surfaces before rinsing (A and B) with vital 
mature biofilm as well as directly after one-time rinsing with 0.2% CHX (C and D), 0.1% CHX (E and F), 
or 0.1% OCT (G and H) with a monolayer of non-vital bacteria. Permission has been obtained to reuse 
images published in the journal Clinical Oral Investigations and Journal of Dental Research (MARTÍNEZ-
HERNÁNDEZ et al., 2020; REDA et al., 2021a). 
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Fig. 22: Effect of chlorhexidine (CHX) and octendine (OCT) on biofilm disruption. The figure shows 
representative fluorescence images after LIVE/DEAD staining (living bacteria are stained green and dead 
bacteria are stained red) of the 48 h-biofilm formed on enamel surfaces before rinsing (A and B) with vital 
mature biofilm as well as of the 72-h biofilm after two-times rinsing with 0.2% CHX (C and D), 0.1% CHX 
(E and F), or 0.1% OCT (G and H) with a monolayer of non-vital bacteria. Permission has been obtained to 
reuse images published in the Journal of Dental Research (REDA et al., 2021a). 
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Fig. 23: Quantification of biofilm coverage (A) and bacterial vitality (B) at 48 h and 72 h. In comparison 
with the control before rinsing, 0.2% chlorhexidine (CHX) and 0.1% octenidine (OCT) rinsing solutions 
caused a significant reduction in the biofilm coverage and biofilm vitality. Rinsing with 0.1% CHX caused 
a significant reduction in the biofilm vitality only. There are significant differences in vitality and coverage 
parameters between 0.2% CHX and 0.1% CHX as well as between 0.1% OCT and 0.1% CHX. Analysed 
were 280 independent images; min to max values are shown as floating bars and the middle line refers to the 
mean. Statistically significant association: (p < 0.05). ns: not significant. 
4.2.2.2 TEM-evaluation 
The disruption effect of CHX and OCT rinses on a complex biofilm was also evaluated by TEM 
analysis. The results are presented in figures 24 and 25. After 48 h of intraoral exposure (Fig. 24 A and 
B, Fig. 25 A and B), a pellicle layer was observed on the control surfaces consistently covering the 
enamel surfaces. Additionally, a multilayer biofilm was seen coating the surface of the control 
specimens. The microorganisms were found prevalently well preserved and trying to proliferate. 
After a single CHX or OCT rinsing (after 48 h of intraoral exposure), alterations of the biofilm 
were observed. The number of bacterial sheets covering the treated specimens was reduced and the 
bacteria detected within the treated biofilms were damaged. After a second CHX or OCT rinse and a 
Results 
- 55 - 
 
total of 72 h intraoral exposure, further disintegration of the biofilm was found. The percentage of lysed 
bacteria with a coagulated cytoplasm increased (Fig. 25 C-H). 
It is worth noting that the thickness of the biofilm significantly changed between the evaluation at 
48 h without mechanical control of the biofilm (16.7 ± 3.2 µm) and the biofilm thickness after the first 
rinsing with 0.2% CHX (4.1 ± 1.7 µm), 0.1% CHX rinsing (3.2 ± 0.7 µm), or 0.1% OCT rinsing 
(2.1 ± 0.8 µm) (p < 0.001). Additionally, a significant reduction in the biofilm thickness was observed 
between the control specimens, and the thickness of the biofilm observed at 72 h of intraoral exposure 
after two times rinsing with 0.2% CHX (4.3 ± 1.4 µm), 0.1% CHX (2.9 ± 1.6 µm), or 0.1% OCT 
(2.3 ± 0.7 µm) (Fig. 26).  
Again, the biofilm dissolving activity of the CHX and OCT rinses was confirmed by comparing 
TEM images and the numbers of the bacterial layer before oral rinsing and after the application of CHX 
or OCT. On the control surfaces (before the oral rinsing) there was a mature biofilm with multi-layers 
of different oral bacteria (Fig. 24 A and B, Fig. 25 A and B). Whereas after the application of either 
CHX or OCT there was only a mono-layer of microorganisms covering the enamel specimens. 
Moreover, the enamel surfaces were even partly devoid of bacteria after the second CHX or OCT rinsing 
(Fig. 24 C-H, Fig. 25 C-H). Most of the detected bacteria on the treated surfaces revealed a coagulated 
cytoplasm and damaged cell membrane. Lastly, the statistical analyses of the data taken from the TEM 
evaluation confirmed the biofilm disruptive ability of CHX and OCT rinsing and that there were no 
significant differences between the aforementioned agents (Fig. 26). 
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Fig. 24: Effect of chlorhexidine (CHX) and octendine (OCT) on biofilm disruption. The figure shows 
representative TEM micrographs of the 48-h biofilm formed on enamel surfaces before rinsing (A and B) 
with multilayer biofilm as well as directly after one-time rinsing with 0.2% CHX (C and D), 0.1% CHX (E 
and F), or 0.1% OCT (G and H) with monolayer biofilm. * Previous enamel surface. Permission has been 
obtained to reuse images published in the journal Clinical Oral Investigations and Journal of Dental Research 
(MARTÍNEZ-HERNÁNDEZ et al., 2020; REDA et al., 2021a). 
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Fig. 25: Effect of chlorhexidine (CHX) and octendine (OCT) on biofilm disruption. The figure shows 
representative TEM micrographs of the 48-h biofilm formed on enamel surfaces before rinsing (A and B) 
with vital multilayer biofilm as well as the 72-h biofilm after two-time rinsing with 0.2% CHX (C and D), 
0.1% CHX (E and F), or 0.1% OCT (G and H) with monolayer non-vital biofilm. * Previous enamel surface. 
Permission has been obtained to reuse images published in the journal Clinical Oral Investigations and 
Journal of Dental Research (MARTÍNEZ-HERNÁNDEZ et al., 2020; REDA et al., 2021a). 
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Fig. 26: Quantification of biofilm thickness at 48 h and 72 h. In comparison with the control before rinsing, 
chlorhexidine (CHX) and octenidine (OCT) rinsing solutions caused a significant reduction in the biofilm 
thickness. There were no significant differences between 0.2% CHX, 0.1% CHX, or 0.1% OCT. Analysed 
were 70 independent images; min to max values are shown as floating bars and the middle line refers to the 
mean. Statistically significant association: (p < 0.05). ns: not significant. 
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5 Discussion 
Antiseptic products are worldwide used as an adjunctive therapy to improve preventive and treatment 
measures through reducing the bacterial load in the oral cavity, particularly by patients with oral 
diseases such as caries and periodontitis. The antiseptic agent CHX is the most representative of the 
chemo-prophylactic substances. Therefore, in order to monitor the CHX concentrations after oral 
application of different CHX formulations and to evaluate how long CHX remains in different oral sites, 
oral pharmacokinetic experiments as a part of this research were carried out.  
Worth to mention that CHX has some side effects such as tooth discoloration and bitter taste, which 
prevent the prolonged use of this agent. One possible alternative is OCT, a highly active antiseptic agent 
against gram-positive and gram-negative microorganisms. However, the CHX- and OCT-induced 
modifications in the dental biofilm had not been well evaluated and compared especially on natural 
enamel specimens and by using both FM and TEM approaches together. Therefore, part of the current 
work was designed to investigate the effects of CHX and OCT rinses on biofilm formation and biofilm 
disruption on native enamel under in situ conditions. This experiment evaluated bacterial vitality and, 
for the first time, the ultrastructure of dental biofilms under the influence of CHX and OCT solutions.  
 
5.1 Discussion of materials and methods 
5.1.1 Experimental design 
5.1.1.1 In situ biofilm model 
The efficacy of different chemical agents is studied usually on bacterial biofilms which are generated 
either by using in vitro models or in situ models. The in vitro model is based on laboratory techniques 
to produce a biofilm from one or several oral bacteria (GUGGENHEIM et al., 2001). The in vitro studies 
are considered as the first step to investigate the clinical efficacy of oral antiseptics (SHANI et al., 2000; 
SHAPIRO et al., 2002). However, the findings from in vitro experiments should be interpreted with 
caution for many reasons. Foremost, there is a big difference between in vitro and in vivo biofilm 
formation, mainly because of the existence of saliva in the oral cavity which plays a key role in the 
physiological bio-adhesion. As a result, the adhesion process in vivo is totally different from in vitro 
conditions (HANNIG, HANNIG, 2009).  
In addition to the salivary role, both the structural organization of the microbial community in the 
oral biofilm and the modified pattern of gene expression therein cause reduced sensitivity of microbial 
cells to antiseptics (STEWART, CONTERTON, 2001). The complexity of bacterial biofilm may 
prevent the penetration of the antiseptics. Furthermore, the chemical agent can kill and inhibit the 
superficial layer of the microbial biofilm leaving the bacterial cell in the depths of the biofilm 
undamaged. Additionally, the presence of a sub-population of ‘‘persister’’ microorganisms, which are 
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specialized survivor cells, leads to an increased resentence of some biofilms to the antibacterial agents 
(KEREN et al., 2004). Charged polymers also that form part of the biofilm matrix and the neutralizing 
enzymes which are attached to this matrix can bind to oppositely charged inhibitors and deactivate the 
antibacterial power (ALLISON, 2003). Lastly, bacterial cells in the biofilm usually become more 
resistant because of mutations affecting the drug targets on the bacteria or because of the production of 
modifying residues and enzymes, which can react with the inhibitors (STEWART, CONTERTON, 
2001).  
Due to the aforementioned reasons, the oral biofilm is considered as a novel phenotype which can 
lead to a lower sensitivity of the bacteria to antimicrobial agents. That means the MIC for a bacterial 
cell grows on a surface can range from 2- to 1000-fold greater than the same cells grown planktonically 
(STEWART, CONTERTON, 2001; JOHNSON et al., 2002). For example, the MIC of CHX and amine 
fluoride was 300 times and 75 times greater, respectively, when Streptococcus sobrinus was grown as 
a biofilm compared with the MIC for planktonic cells (SHANI et al., 2000). 
Therefore, considering the mentioned drawbacks of in vitro models, there was a desperate need to 
use an in situ model where the biofilm grows in a way similar to the growth pattern inside the oral cavity 
as well as under the same conditions and thereafter evaluating the oral antiseptics efficacy on these in 
situ-formed biofilms (HANNIG, 1999; HANNIG et al., 2013a). In order to accurately replicate oral 
cavity conditions, an in situ approach was adopted in the present study. 
5.1.1.2 The removable mini-splint 
To allow the dental pellicle and oral biofilm to form under in situ conditions on enamel specimens in 
this study, a specific approach was needed to fix these surfaces inside the oral cavity. One option was 
to use a removable acrylic splint which is considered a reliable tool where several enamel surfaces can 
be fixed using the silicone impression material (light body) and then easily removed after the end of the 
experimental time without disturbing the adherent biofilm (PRADA-LÓPEZ et al., 2016). This 
approach can be considered as a valid way for in situ biofilm studies because as stated in a previous 
study there is almost no difference between the normal biofilm formed on the natural tooth and the 
biofilm formed on enamel specimens fixed on acrylic splints (MACPHERSON et al., 1991). 
While this splint model is well accepted by the volunteers because it can be taken out of the mouth 
for a short time to perform the oral hygiene measurements or during meals time, there are also few 
negative aspects concerning this model. The negative aspects of the splint model are the absence of 
food effect on the biofilm development and also these splints can’t be used for long-term experiments 
(more than a few days) because wearing them for extended periods of time will be difficult and 
exhausting for the volunteers.  
Another option was to use dental bonding agents for fixing the specimens inside the oral cavity for 
long time under the effects of food and beverages. Unfortunately, to achieve that, an etching step should 
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be applied to the tooth surface before bonding the specimens which can cause decalcification and minor 
damage to the tooth surface and as a result, this approach was deemed unethical. 
5.1.1.3 Experimental conditions 
All the subjects followed specific experimental criteria to avoid factors that can mislead the obtained 
results because of individual habits of the subjects and to reduce the inter- and intra-individual variations 
in such kind of in situ studies. These criteria include the following points: 
1) Last tooth brushing step should be done at least 30 min before the start of the experiment to avoid 
the interaction between residues of the toothpaste particles and the tested agents (KOLAHI, SOOLARI, 
2006). 
2) Oral hygiene procedures were done during the experimental time without any additional chemical 
agents or toothpastes, again to avoid the interaction between these products and the tested agent and to 
avoid the additional misleading antibacterial effects which can be delivered from the chemical agents 
or toothpastes. 
3) Each experimental trial was started in the morning and the last food meal was taken at least one hour 
before each tested product to avoid the interaction between the food particles and the tested agents at 
the application time point.  
4) All the subjects had almost matched lunchtime points to have a similar effect at the same time on the 
substantivity of the test products by all the subjects.  
5) In situ sample collections by standardized micro-brushes in the first retention experiment resulted in 
comparable data groups from saliva as well as from the other oral locations because all CHX 
concentrations were correlated to the wetted tip volume of the micro-brushes. This point of reference 
was independent of different and non-standardisable superficial abrasion area sizes within the oral 
cavity. The calculated CHX concentrations cannot be given as amounts of CHX per defined tissue area, 
because the present data are independent of the wiped area size. To gain that specific information, 
surgical sections of defined sizes would be necessary to the CHX retention evaluation in this part, which 
is ethically not allowed on humans. In contrast, the used sampling approach is minimally invasive, not 
even inducing any mucosal irritation.  
6) In the second retention study and for a more standardized experimental sampling, 2 µl samples were 
taken from saliva and buccal mucosa pellicle in addition to the dental pellicle sample formed on a 
standardized enamel surface (11.35 mm²). 
7) The experimental design of the work was a crossover design where repeated measurements were 
conducted. In this design, the subjects cross over from one treatment to another during the course of the 
experiment. Whereas in the parallel design the volunteers are randomized to a specific treatment and 
remain on that treatment throughout the duration of the experiment. The crossover design could yield 
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more efficient comparisons between treatments than a parallel design by reducing the variation between 
experimental runs, which could occur if every run started with a new volunteer. The utilization of the 
crossover design seems more reasonable because each subject serves as his/her own matched control. 
However, the major disadvantage in the crossover design is that carryover effects which is defined as 
the effects of previous treatment on the current treatment. In other words, if a patient receives therapy A 
during the first experimental trial and therapy B during the second trial, then the obtained values from 
the second trial could be a result of the direct effect of therapy B applied during the second run, and/or 
the carryover or residual effect of treatment A. Significant carryover effects can bias the interpretation 
of data analysis and lead to statistical bias. To eliminate the impact of these carryover effects, 
incorporation of long washout periods in the experimental design of the cross over studies should be 
considered. 
8) In the present work, an important washout period of 10 days was applied. A washout period is defined 
as the time between two treatments. That means, instead of stopping and then immediately starting the 
new treatment, there will be a period of time to eliminate the activity of the first treatment and to restore 
the original conditions before a new experimental trial. In this way, the results of the next treatment will 
be not violated by the carryover effects from previous treatments. The rationale for using the washout 
period is to nullify any negative bias effects that a crossover experiment may have. The main aim of 
using a washout period in the retention studies was to eliminate any rest of CHX in the oral cavity from 
a treatment regimen which can affect the retention values of the next treatment regimen. Whereas the 
aim in the anti-biofilm study was to restore the normal bacterial ecosystem before testing a new active 
agent. 
9) The volunteers should not use any medication before or during the experimental time to avoid any 
additional antibacterial effect on the studied biofilm beside the effect of the tested antiseptics. 
10) In the present work, the biofilms were formed on the enamel specimens for 24 h, 48 h, and even 
72 h to evaluate the effects of the test products on a real mature biofilm. 
5.1.2 MALDI-TOF evaluation 
Previously, there were many analytical methods for CHX determination starting from direct ultraviolet 
spectroscopy which was a simple method and easy to carry out, but not specific for CHX detection 
(JENSEN, CHRISTENSEN, 1971). The determination was disturbed by endogenous components from 
the salivary matrix (PESONEM et al., 1995). Therefore a method based on the use of radiolabel 14C 
(BONESVOLL et al., 1974a) and a fluorometric method (DE VRIES et al., 1991) have been conducted. 
The first one was able to detect CHX in saliva 24 h after administration due to the higher sensitivity of 
the radioisotope techniques and also able to use the whole saliva sample. In contrast, the reported 
fluorometric method was unable to analyse the whole saliva samples and their linearity limitation 
(6.7 - 20 μg/ml) fails to determine lower and higher concentrations of CHX in saliva samples. Different 
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approaches of high-performance liquid chromatographic (HPLC) has been used for CHX detection 
(LAM et al., 1993; MEDLICOTT et al., 1994; PESONEM et al., 1995; TSUCHIYA et al., 1999), and 
also solid-phase micro extraction (SPME) was used for pharmacokinetic investigation (MUSTEATE, 
PAWLISZYN, 2005). In 2015, MALDI-TOF MS technique was used to detect CHX at therapeutic 
concentrations in microtome slices of a bacterially contaminated model wound treated with the CHX 
(HAMERLY et al., 2015). 
Although HPLC and SPME are relatively selective and accurate, they require many extraction 
procedures and more steps for calculating the CHX concentrations. Even more, sample preparation can 
be laborious and time-consuming (FIORENTINO et al., 2010). Thus, while both techniques are useful, 
both of them impose some restrictions when compared to the sensitivity, speed, and accuracy offered 
by MALDI-MS. Furthermore, MALDI-TOF MS was used in the present study for analysing different 
kinds of samples from different oral locations besides the saliva. This mass spectrometry method allows 
high sample throughput, even if 5 replicate measurements were performed for one sample, because the 
laser shots were completed within 2 s for each measurement. Additionally, none of the samples needed 
time-consuming sample preparation, enrichment steps, or clean-up-techniques. Moreover, the 
characteristic isotope pattern of the two chlorine isotopes (35Cl/37Cl at ~3:1 ratio) easily allowed the 
recognition of CHX in the measured mass spectra, as human endogenous molecules do not contain 
chlorine covalently bound to organic components. That means, neither salivary compounds nor 
ingestion of food and beverages interfered with the identification of CHX isotope patterns.  
The low limit of quantification in the present experiment (1.5 ng/ml) and the adequate range of 
linearity demonstrate the MALDI-technique as a high sensitivity approach to determine and quantify 
CHX in experimental samples. 
Taken together, samples collecting and processing for the MS-measurement in the MALDI-TOF 
approach is relatively simple. There is no need for any additional procedures or cleaning steps of the 
samples before the quantification. Therefore, the MALDI-TOF technique appears to be a useful method 
for the pharmacokinetic investigation of different oral medications in the scientific and industrial 
domains. This method can answer questions about the availability, substantivity, and hence the 
frequency of application required for a certain therapy.  
5.1.3 Fluorescence microscopy evaluation after LIVE/DEAD staining 
Traditionally, bacterial vitality is determined by plating a diluted bacterial sample on a solid medium 
followed by counting the colonies that form. This is the routine procedure in microbiology laboratories 
worldwide. However, this technology in the oral biofilm field has several shortcomings. First and 
foremost, only half of the oral bacterial strains are cultivable (AAS et al., 2005). Additionally, there 
will be a lot of bacterial cells in the oral cavity which are still vital but are not able to form colonies on 
nutrient media despite them having other measurable activity and requiring special conditions to 
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proliferate. Therefore, the plate count technique always gives an underestimation of the actual vitality 
of a biofilm sample. It was even proposed that, for stressed cells, plate counts could give vitality to less 
than 50% of the truly vital inhabitants (JONES, 1987). Another drawback of this technique involves a 
significant delay to obtain the final results, usually 24 h to 5 days. Such a delay can be problematic 
especially when the results are needed as soon as possible.  
For the aforementioned reasons and more, many attempts have been made to establish quick 
techniques for the determination of bacterial vitality, usually based on the exclusion, uptake, or 
metabolism of coloured stains. One of these methods is the fluorescence-based, two-colour vitality 
assays LIVE/DEAD staining (LDS), using BacLight™ bacterial vitality kit. This kit consists of two 
dyes, propidium iodide (PI) and SYTO 9, which both stain nucleic acids. SYTO 9 is a green fluorescent 
and membrane-permeable molecule which stains all cells. In contrast, PI is a red intercalating stain and 
membrane impermeable. It is therefore excluded by “healthy” cells. When both dyes are presented 
within a damaged bacterial cell, the PI, with its stronger affinity toward nucleic acids, will displace the 
SYTO 9 and cells will fluoresce in red. Consequently, the percentage of bacterial adherence (coverage) 
and the vitality percentage can be determined. 
The LDS approach followed by fluorescence microscopic evaluation has been used in previous 
experiments because of its high reliability, simplified preparation steps, and rapidity (HANNIG et al., 
2013a; HANNIG et al., 2013b). This approach was considered as a useful tool for evaluating potential 
anti-biofilm effects of mouth rinses by determining the percentage of adherent bacteria on a surface, 
together with how vital they are during biofilm formation (WEIGER et al., 1995; AL-AHMAD et al., 
2008). Therefore, fluorescence microscopy after LDS was used in the present study to evaluate and 
compare the efficacy of different mouth rinses on both aspects: the anti-biofilm effect and the biofilm 
disruption activity. 
The counting procedure can be applied to evaluate the bacterial colonization and to calculate the 
vitality percentage, especially when few bacteria are attached to the surface as initial biofilm or in 
samples of salivary flora (HANNIG et al., 2007; TAWAKOLI et al., 2013). In contrast, by mature 
biofilms, it is difficult to determine and count single bacteria in the colonies and with-in dentinal 
tubules. Thus, a scoring system has been developed to evaluate the bacterial colonization and for the 
assessment of the ratio between red and green fluorescence (i.e., the ratio between dead and alive 
bacteria) (RUPF et al., 2012; FENG et al., 2015). 
In spite of the rapidity of the scoring system in regards to biofilm qualitative and quantitative 
evaluation, it can only give approximate values especially for the mature biofilm where the living 
bacteria with green fluorescence are on the superficial layer hiding the dead bacteria under them, which 
can give a misleading evaluation toward more viable percentage. Furthermore, there is an additional 
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drawback in the scoring system which is the personal bias where every individual can see the same 
fluorescence image in a different way. 
To overcome these aforementioned negative aspects, the biofilm evaluation in this study was done 
using a digital program called ImageJ which is able to measure the whole FM image area in addition to 
the biofilm covered area and then the percentage of the bacterial colonization can be easily calculated. 
This program is also able to measure the grey integrated density of both FM channels, the red one 
(indicates to dead bacteria) and the green one (indicates to living bacteria) and then consequently the 
vitality percentage can be calculated. 
5.1.4 Electron microscopic investigation 
TEM is a common method for evaluating the ultrastructural pattern of oral biofilm and morphological 
appearance (BRECX, THEILADE, 1984; HANNIG, JOINER, 2006). Thus, TEM evaluation is very 
useful for studying the ultrastructural alterations in oral biofilm induced by different oral antiseptics. 
TEM is the gold standard for biofilm evaluation at the micro- and nano-scale levels. This detailed 
visualization of the biofilm structure, as well as bacterial morphology, will help to get further 
information about the action mechanisms behind the clinical efficacy of CHX and OCT. Furthermore, 
it makes it possible to accurately measure the biofilm thickness in the control conditions and under the 
influence of the antibacterial agents as well. Unfortunately, and due to huge efforts for sample 
preparation, TEM can be considered as a laborious and time-consuming evaluation method. An 
additional issue is the small evaluated ultrathin-section (50 - 80 nm) taken out of a small enamel surface, 
(3 mm x 3 mm), which is sometimes not reflecting the general situation of the bacterial biofilm either 
under the control or test conditions. However, by using good quality TEM images it is practical to get 
a meaningful impression of the oral biofilm at the ultrastructural level. 
As described above, there are different methods to evaluate the oral biofilms, thus it would be of 
great value to use the advantages of several investigating techniques at the same time to have a detailed, 
comprehensive view about the oral biofilm both in a control condition and under the influence of 
different oral antiseptics. The vital fluorescence approach gives an overview of the microbial 
colonization and vitality pattern, whereas TEM gives detailed information at the ultrastructural level. 
Therefore, this combination of the two methods is able to build a ‘three-dimensional’ ultra-structure 
vision of the oral biofilms in addition to the vitality evaluation, which is very important to investigate 
the effects of the chemical antiseptics on the quality and the quantity of oral biofilm. This is of great 
importance for evaluating the efficiency of oral hygiene agents for biofilm control. 
5.1.5 Statistical analysis  
The statistic tests have great importance, especially in comparative studies. They help the researcher to 
find out if there are any significant differences between the experimental groups and consequently 
between several treatment agents. In some cases, the difference between the control group and very 
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effective treatment is quite obvious and no further tests are needed to prove that, whereas when different 
treatment regimens are investigated, statistic tests are needed to clarify if the detected differences 
between the treatment groups are significant or not. The decision, which statistical tests should be used 
is not easy or straightforward. There are many considerations and variances that should be taken into 
consideration before choosing the appropriate statistical test such as the distribution pattern, sample 
size, pairing, etc. 
In this study and for the retention experiments, repeated measures of two-way analysis of variance 
ANOVA was taken as a statistical test because two factors were changing during the experiments. In 
the first retention experiment, the time of sampling and the oral site were changing. In the second 
retention study, the sampling time was changing as well as the CHX treatment formulation and regimen. 
Furthermore, repeated measures test by both factors (paired test) was chosen because oral samples were 
taken in the first retention experiment from the same subject and the subjects in the second retention 
experiment cross over from one therapy to another during the experiment. Multiple comparisons were 
conducted in the retention experiments with the Tukey test to find out if there were any significant 
differences in oral CHX retention between the different oral sites in the first experiment and between 
the different CHX formulations and regimens in the second. 
The statistic test in the anti-biofilm experiments was Repeated Measures of one-way ANOVA with 
multiple comparisons. The reasons behind choosing a parametric test were the following:  
1) According to the normality test (Shapiro-Wilk test), the statistic units in the experimental groups 
were sampled from a population that follows a Gaussian distribution or at least most of the data were 
not inconsistent with a Gaussian distribution.  
2) In this work, the statistic units were 5 in each test group and for that it was better to avoid 
Nonparametric tests, because when the number of samples is too small (less than 7 values) the 
Nonparametric tests have little power to detect the differences between the groups.  
Repeated measures test (paired test) was also used because treatments were given repeatedly to 
each subject. It is important to note that the Repeated-measures ANOVA test is quite sensitive to 
violations of the assumption of sphericity or circularity. Violation of sphericity means that factors from 
treatment A will affect the results obtained from treatment B in the crossover design. This will happen 
when the repeated measurements are made too close together so that random factors from previous 
treatment are not washed out completely or dissipate before the start of the new treatment run in the 
crossover experimental design. This will cause a particular value to be high (or low) in the next 
measurement.  
To avoid violating the assumption of sphericity in the present work, an important washout period 
of 10 days was applied. Furthermore, the order of treatments was random and each subject followed a 
different treatment sequence in his experimental trial. Additionally, Geisser and Greenhouse correction 
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was added to the Repeated Measures-ANOVA to avoid any statistic bias that could occur from the 
violation of the assumption of circularity. The Geisser and Greenhouse correction was particularly 
applied in the anti-biofilm study because of the usage of highly effective agents such as CHX and OCT 
in the treatment groups. Therefore, when there is a doubt that the treatment effect is not completely 
washed in spite of the washout period, it would be better to add Geisser and Greenhouse correction. It 
reduces the values of the degrees of freedom, and thus increases the p-value. Multiple comparisons with 
the Tukey test were done to compare the control group with each therapy group and to compare each 
therapy group with the other. 
Lastly, the Brown-Forsythe test was applied for the assessment of equal variances because it is less 
sensitive to small deviations from normality. Bartlett's test was not recommended from the statistic 
program because it is more sensitive even for slight deviation from Gaussian ideal and may give a small 
p-value even when the differences among standard deviations are negligible. 
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5.2 Discussion of results 
5.2.1 Discussion of retention results 
Oral pharmacokinetic studies were carried out in order to monitor the CHX retention after application 
and to estimate how long CHX stays at bactericidal or bacteriostatic concentrations in different oral 
locations. Such kind of experiments is also needed to obtain more information about some factors that 
affect the retention of the antiseptic in the oral cavity, such as drug concentration, application time, and 
delivery system. 
The effective concentrations of CHX were evaluated previously in earlier studies (STANLEY et 
al., 1989; TSUCHIYA et al., 1994). The MIC of CHX for primary cariogenic bacteria like 
Streptococcus mutans, Actinomycetes, or Lactobacilli ssp. ranged from 0.39 to 6.25 µg/ml (TSUCHIYA 
et al., 1994) and the MICs for 52 subgingival bacterial strains ranged from 8 to 250 µg/ml (STANLEY 
et al., 1989). In the current work, mean CHX-retentions ranging from 0.6 to 18.4 µg/ml were determined 
after 11 h in the mouth. Therefore, it can be stated that the antimicrobial activity of CHX against several 
species of pathogenic oral microorganisms remains for a considerable time after CHX rinsing. 
Up to now, the retention of CHX was mainly determined in saliva (LAM et al., 1993; 
MEDLICOTT et al., 1994; PESONEM et al., 1995) or in saliva-coated hydroxyapatite and buccal 
epithelial cells in vitro (TSUCHIYA et al., 1999). Additionally, it was proved in former experiments 
that CHX rinsing leads to changes in the dental pellicle layer such as increasing the pellicle thickness 
(CARPENTER et al., 2005; JOINER et al., 2006; DE SOUZA-E-SILVA et al., 2017). Moreover, 
brownish tooth staining after prolonged CHX usage obviously suggests that there must be a CHX 
associated modification of the dental pellicle. Until the present study, there was missing proof that CHX 
is retained and enriched onto and within the acquired dental pellicle formed in situ. However, we 
showed in the current work that CHX, in fact, adsorbs onto and within the dental pellicle under in situ 
conditions and that the dental pellicle acts as a reservoir for CHX-release towards the saliva for a 
considerable time after CHX application. 
The usage of MALDI-TOF MS has shown that CHX retention varied at different oral locations in 
each subject and between subjects. The inter-individual differences between the subjects were rather 
large and led to a high standard deviation of the CHX retention. This could be due to the individual 
difference between the volunteers in the oral environment (especially oral pH value) in addition to 
dietary habits during the time of the experiment. For example, consuming acidic foods and drinks can 
lower the pH within the oral cavity which can lead to reduced CHX retention (BONESVOLL et al., 
1974b). Worth noting that many previous studies had reported such an inter-individual variation after 
CHX mouth rinsing (BONESVOLL et al., 1974a; MEDLICOTT et al., 1994; PESONEM et al., 1995; 
TSUCHIYA et al., 1999). 
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A fast reduction of CHX retention in the first few hours after mouth rinsing was noticed in the 
present study. The main meal intake could be the rational reason for such a rapid decline. This might 
be attributed to the interaction between negatively charged food particles with positively charged CHX-
molecules. This interaction could lead to the CHX desorption from oral surfaces. Nevertheless, a 
significant quantity of CHX still presented in the oral cavity for an extended time even after the one-
time 30 s oral rinsing. Such a rapid decline in oral CHX retention after food and beverage was also 
observed in former experiments (MEDLICOTT et al., 1994; TSUCHIYA et al., 1999).  
As can be seen from the retention experiments results (Tables 2 and 5), the concentrations of 
salivary CHX stayed at microgram pro millilitre scales up to 10 h after oral application. These findings 
are in good agreement with the results from former experiments of CHX retention in saliva (JENSEN, 
CHRISTENSEN, 1971; MEDLICOTT et al., 1994; PESONEM et al., 1995; TSUCHIYA et al., 1999; 
MUSTEATA, PAWLISZYN, 2005). 
The retention of CHX at the buccal mucosa was significantly higher than the CHX-retention 
detected in saliva at all-time points. This elevated retention was also clear in the dental pellicle. Such 
retention might be attributed to the high adsorption of CHX to the dental pellicle and mucosal pellicle. 
These findings agree with a former in vitro experiment proposing that the existence of proteins in 
pellicles and buccal epithelial cell walls encourage the adsorption of CHX (TSUCHIYA et al., 1999).  
The retention of CHX in the anterior labial mucosa was slightly, but not significantly higher than 
in the posterior buccal mucosa (p = 0.89) (Table 2). It is probably that CHX was more diluted at the 
posterior locations as they are nearer to the main salivary glands (parotid glands). Moreover, there might 
be an abrasive impact against the retained CHX on the posterior location during food chewing.  
The highest persistent of CHX in the mouth was detected in the interdental area. The enriched and 
immobilized CHX which is kept in the interdental area appears to be protected from dilution and 
abrasive effects of eating and drinking. 
Food intake is considered to be an effective factor for reducing the retention of CHX in the oral 
cavity (JONES, 1997). To investigate the food effect in current work, CHX retention during fasting was 
evaluated. The results showed clearly high retention of CHX, which can be directly attributed to the 
absence of dilution and abrasion effects of beverages and food mastication. These results agree with 
previous studies concerning the effects of food intake on the substantivity of CHX (MEDLICOTT et 
al., 1994; TSUCHIYA et al., 1999; MUSTEATA, PAWLISZYN, 2005). It is worth noting that the long-
lasting retention of CHX at higher concentrations in the oral cavity indicates the high stability of CHX 
in the oral cavity without decomposition over time. The mechanical effects during the consumption of 
food and beverages are the most important factor for reducing CHX concentrations after the application. 
Additionally, such a high retention of CHX in the fasting time could point to the importance of using it 
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directly before sleeping to keep it in high concentrations in the oral cavity during the night in a similar 
way to fasting and to have the best antibacterial effects after rinsing. 
Regarding the effect of CHX formulas and regimens on oral retention, when identical amounts of 
10 ml from CHX mouth solution were used, an increase in either the concentration or the rinsing time 
led to a slight rise in the CHX retention in saliva, mucosal pellicle, and dental pellicle. The maximum 
level of CHX retention was achieved with the 0.2% CHX rinsing for 60 s. While the differences in CHX 
retention between the four rinsing protocols were not statistically significant neither in saliva nor in the 
dental pellicle, the 0.2% CHX rinsing for 60 s, however, caused significantly higher retention than 
0.12% at the buccal mucosa. Such retention results explain the conclusion of a systemic review 
(BERCHIER et al., 2010) where they found that with regards to biofilm inhibition effect; there was a 
small, but significant difference in favour of the 0.2% CHX solution. It was reported also in previously 
published studies that there was higher retention by rising the CHX concentration from 0.1 mg/ml to 
1 mg/ml (TSUCHIYA et al., 1999). Bonesvoll and co-workers also raised CHX retention by raising the 
concentration or increasing the rinsing time (BONESVOLL et al., 1974b). They also noticed that there 
was a slight deviation towards less retention at the highest concentration tested. This means that there 
is a binding capacity for CHX in the oral surfaces, which explains why there was only a small difference 
in retention between 0.2% and 0.12% in favour of the higher one. Additionally, this finding indicates 
that increasing the concentrations of CHX for more than 0.2% or rinsing with more than 10 ml (more 
than 20 mg CHX dose) will not induce remarkable higher CHX retention and more persistent 
bacteriostatic activity because of the binding capacity for CHX in the oral cavity. 
Attempts to overcome the side effects of prolonged CHX use have resulted in the development of 
different delivery systems and proposing several CHX formulations, which employ little amounts of 
CHX and deliver the drug to specific areas in the oral cavity. The CHX spray is one of these 
formulations, which delivers small dose from CHX of approximately one-seventh of the dose used in a 
0.2% rinsing protocol and obtains, as shown in the present study, a considerable CHX retention and 
good substantivity for at least 12 h. Furthermore, there were no statistically significant differences in 
CHX retention in saliva and dental pellicle between the rinsing protocols and spray application with an 
exception of 0.2% CHX for 60 s where there was more CHX retention. Such results indicate that low 
dose from CHX solutions delivered by the spray system could provide adjunctive benefits to oral 
hygiene and gingival health with minimal side effects. In accordance with that, it was stated in previous 
studies that CHX retention after spray application is able to provide almost the same beneficial biofilm-
inhibiting effects as it provided from rinsing solution (DEVER, 1979; KALAGA et al., 1989a; 
STOEKEN et al., 2007).  
The spray approach is particularly useful for elderly people and physically and mentally 
handicapped groups (FRANCIS et al., 1987a, b; KALAGA et al., 1989b; BURTNER et al., 1991; 
CLAVERO et al., 2003; VIANA et al., 2014). This method also allows focusing on the treatment of 
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specific regions such as periodontal or implants surgical sites (FRANCETTI et al., 2000; FRANCETTI 
et al., 2004). 
It was thought that adding CHX in the dentifrice formulations will be helpful for patients with 
periodontal disease to get beneficial approaches, mechanical and chemical cleaning. However, 
components, in which pastes and gels are usually formulated, are from anionic substances such as 
sodium lauryl sulphate (SLS), which interferes with the action and bioavailability of CHX via forming 
salts of low solubility and low antibacterial activity (KOLAHI, SOOLARI, 2006). Therefore, two 
different kinds of CHX toothpaste were tested in the current work, one with SLS (paroex) and another 
without it (curasept), to evaluate the retention of CHX in the oral cavity after tooth brushing and the 
effect of SLS on such retention.  
In this study, no statistically significant differences were observed between the toothpaste with 
SLS and the one without SLS in regard to the retention of CHX in the saliva, buccal mucosa, and dental 
pellicle. 
The results showed that CHX toothpaste is retained in the oral cavity at low concentration and not 
to the same extent as a CHX mouth rinse or even after CHX spray application. Differences in CHX 
retention between CHX toothpaste and other CHX formulations in the three oral locations were highly 
significant. The reason behind this low retention could be due to the mechanical action of the tooth 
brushing that can remove the newly attached CHX particles at the dental pellicle. Furthermore, rinsing 
the mouth several times with water after tooth brushing will also wash away most of the CHX particles 
from the oral cavity surfaces. In contrast, most of the retained CHX after mouth rinsing or spray 
application will stay in the oral cavity for a more extended time after application because usually the 
patient does not rinse the mouth with water after using the mouthwash or spray. To overcome the 
problem of washing CHX after tooth brushing, it was suggested in previous studies that CHX gel could 
be delivered in trays or applied directly on teeth surfaces with the finger (PAI et al., 2004). This style 
of application, especially with high CHX concentration, has provided more antibacterial efficiency and 
caused a significant reduction of plaque scores and gingival index (SUPRANOTO et al., 2015). Such a 
reduction was comparable with the mouth rinse in some studies (PAI et al., 2004; SLOT et al., 2010; 
MAGAZ et al., 2018). 
Another factor that can influence the retention of CHX after toothpaste application is the CHX 
concentration, i.e. dosage of the drug. It was concluded in a systematic review (SLOT et al., 2014) that 
the positive effects of CHX toothpaste were noticed only when the concentration of CHX was more 
than 0.6%. Therefore, when 0.12% CHX toothpaste in this study was used, the dosage was 1.2 mg 
which is clearly lower than a 20 mg CHX dose delivered by rinsing and this could explain why there 
was negligible retention after tooth brushing and almost no substantivity 2 h thereafter.  
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Worth noting that the results in the present experiment mirrors (in a clinical setting) the conclusion 
from a systematic review (SUPRANOTO et al., 2015), which showed that CHX mouth rinse is 
significantly more efficient on biofilm control than CHX toothpaste or gel because CHX retention after 
mouth rinsing is much higher than the retention after CHX toothpaste application. 
Returning to the CHX MICs of oral bacteria and according to the retention study results, the 
antibacterial concentrations for the elimination of primary cariogenic bacteria such as Streptococcus 
mutans, Actinomycetes, and Lactobacilli were between 0.36 and 6.25 µg/ml (TSUCHIYA et al., 1994). 
These concentrations were achieved by all the CHX regimens including the toothpaste. Whereas the 
needed CHX concentrations for the subgingival bacteria responsible for periodontal diseases which 
ranged between 8 and 250 µg/ml (Stanley et al., 1989) were only achieved by the CHX rinsing solutions 
or at least from spray application, but not after the toothpaste application which had given us at most 
2 µg/ml 2 h after tooth brushing.  
It is important to mention that the CHX retention values in saliva and at the mucosal pellicle after 
the application of 0.2% CHX for 30 s in the second retention experiment were different than the values 
in the first one, especially at the first time point. This is presumably due to the differences in the study 
design, evaluation time points, and sampling technique between both retention studies.  
Generally, in the present study, 0.2% CHX for 60 s gave the best retention values that provide 
persistent antibacterial activity in the oral cavity. In accordance with that, García-Caballero and 
co-workers found that rinsing with 0.2% CHX had the greatest persistent antibacterial impact on 
salivary microorganisms, underlining the effect of the concentration and form of application on the 
CHX substantivity (GARCÍA-CABALLERO et al., 2009).  
Taking together, the results of the present study showed that CHX can be present and potentially 
active against some pathogenic bacteria in the oral cavity for at least 12 h after oral application. 
Additionally, the CHX concentration and the delivery system play an essential role in the CHX retention 
in the oral cavity after application. 
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5.2.2 Discussion of anti-biofilm results 
The CHX- and OCT-induced morphological alterations in the dental biofilm have not been well 
investigated and compared yet, especially using the TEM technique on real enamel surfaces. Therefore, 
the current work was designed to examine and compare the anti-biofilm and the biofilm disruption 
effects induced by CHX and OCT mouth rinse every 12 h under in situ conditions. 
5.2.2.1 Chlorhexidine and octenidine rinsing affects in situ biofilm formation on enamel 
Dental biofilm is defined as a microbial community embedded in the bacterial matrix on the tooth 
surface (SOCRANSKY, HAFFAJEE, 2002; MARSH, 2004). In general, the development of bacterial 
biofilm could be seen as an increase in the microbial quantity and the formation of big aggregates, 
including density and the diversity of the microbiota (HANNIG, JOINER, 2006). 
In the present study, the 24-h control biofilms (water rinsing) in the FM evaluations were identified 
as microbial communities colonizing the enamel specimens, covering about 20% of the surface. 
Subsequently, a remarkable increase in the number of bacteria and the complexity of the biofilm 
structure was noticed between 24 and 48 h of intraoral exposure. The 48-h control biofilms were 
covering about 63% of the enamel surfaces. The comparison of biofilm images between 24- and 48-time 
points leads us to conclude that the structural complexity increased with increasing biofilm age and 
thickness. This condition was also observed in previous studies (ZAURA-ARITE et al., 2001; DIGE et 
al., 2009). Microbial cell division and fibril-like constructions between bacteria in the 48-h biofilm can 
be considered as a sign of microbial proliferation and bacterial coaggregation that leads to further 
biofilm maturation and the formation of multi-layered colonies. The control enamel surfaces (water 
rinsing) were covered by a mature and complex bacterial biofilm with a mean bacterial vitality of around 
70% at 24-and 48-h evaluation times. This finding is in good agreement with previous in situ studies 
that have shown that dental biofilm vitality over 2- and 3-day periods is between 60 and 77% 
(ARWEILER et al., 2004; AUSCHILL et al., 2005).  
Worth mentioning is that the inter-subject variations in the biofilm vitality, coverage, structure, 
and thickness that was seen by FM and TEM analyses might be attributed to individual factors, such as 
salivary flow rate and dietary habits. 
Evident anti-biofilm activity of CHX and OCT solutions was confirmed in the current work by 
investigating the microbial vitality, biofilm coverage, biofilm thickness, and ultrastructure. A low 
presence of microorganisms or even a total absence of bacteria was detected after CHX or OCT 
application, supporting the well-established antibacterial features of CHX (JONES, 1997) and OCT 
(ASSADIAN, 2016). All the aforementioned investigated parameters of treated biofilms showed 
significant differences in comparison to the parameters of control biofilms. This anti-biofilm activity of 
CHX and OCT was clear at 24- and 48-h assessment points and was confirmed by a significant reduction 
in the mean values of oral bacteria colonization. In parallel with the strong reduction of the bacterial 
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colonization by all the rinses, a comparable dramatic reduction of bacterial vitality was detected. It was 
significantly reduced to less than 10% after CHX or OCT application.  
This clear anti-biofilm effect is mostly attributed to the bactericidal activity of CHX and OCT on 
the oral bacteria directly after application. They act on the bacterial cell membrane and disrupt the 
membrane integrity and then they promote the formation of vesicles and precipitation in the cytoplasm, 
which leads in the end to microbial death (BRECX, THEILADE, 1984; JONES, 1997; HUBNER et al., 
2010; ASSADIAN, 2016).  
In this context, it has been stated in former studies that the usage of 0.2% CHX leads to an 
immediate reduction of the bacterial vitality (≥90%) in the salivary microorganisms (TOMÁS et al., 
2009; COUSIDO et al., 2010; GARCÍA-CABALLERO et al., 2013). OCT was also found to be 
extremely effective in reducing Streptococcus mutans levels in saliva and compared favourably with 
CHX (KOCAK et al., 2009).  
As time passes, both antibacterial agents are present at low concentrations in the oral cavity due to 
the dilution effect of saliva as well as food and beverages effects. In such concentrations, both agents 
exhibit bacteriostatic effects (TOMÁS et al., 2008; DOGAN et al., 2008; DOGAN et al., 2009). Hence, 
the further bacterial adherence is hindered and the microorganism available to establish a biofilm or 
attach to an existing biofilm are clearly reduced (NEWCOMBE et al., 1995; TOMÁS et al., 2009; RUPF 
et al., 2012), which is in agreement with the findings detected in the present study. Similarly, a previous 
in situ experiment has shown an important reduction of bacterial vitality to 20% after the CHX 
application (AUSCHILL et al., 2005). The experimental differences in that study compared to the 
present work are the use of glass specimens and the reduced contact of the rinses to the specimens 
because of the splint design, which led to a lower antibacterial effect in comparison to the present study. 
It was shown also in another study that ex vivo CHX application remarkably reduced the microbial 
vitality in 3-day biofilms from 67% in control biofilms to 2% and 0.7% in CHX-treated biofilms at 
1 and 10 minutes, respectively (VON OHLE et al., 2010).  
In the case of OCT, a complete killing of Streptococcus salivarius biofilms was detected after the 
exposure to 0.1% OCT for at least 30 s in vitro (AL-SEBAIE, 2014). Furthermore, Sennhenn-Kirchner 
and co-workers investigated the antibacterial activity of OCT on biofilms created by aerobic oral 
microorganism on rough titanium specimens. The experiment showed that the application of OCT for 
8 min caused a clear reduction of the biofilm vitality by 99.8% (SENNHENN-KIRCHNER et al., 2010). 
In the comparison between the different treatment regimens concerning the tested biofilm 
parameters, at the 24-h evaluation point, there was only a significant difference between 0.1% CHX 
and 0.1% OCT in regards to the biofilm vitality. At 48 h, 0.2% CHX and 0.1% OCT were significantly 
more effective than 0.1% CHX regarding the biofilm coverage.  
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It is worth mentioning that the higher retention detected after using higher CHX concentration in 
the first part of the present work (retention study) can explain why 0.2% CHX was more effective as an 
anti-biofilm agent in compression with the 0.12% CHX. 
A meaningful observation was made in several studies that 0.1% OCT as an antimicrobial agent 
was better than many other agents such as polyvinylpyrrolidone-iodine and even CHX. It was stated in 
a previous study that OCT is quite active in reducing salivary and cariogenic microbial amount after 
15, 30, 60, and 120 min (DOGAN et al., 2008). Furthermore, the same working group found that the 
use of OCT for 5 days caused the most significant reduction in cariogenic bacteria with greater 
antimicrobial activity than 0.2% CHX and 7.5% polyvinylpyrrolidone-iodine (DOGAN et al., 2009). 
Additionally, it was found also that OCT has a similar and even better antibacterial activity than CHX 
and NaOCl against Staphylococcus epidermidis (CHUM et al., 2019).  
It is worth mentioning that an effective anti-bacterial agent is the one that has a direct (bactericidal) 
and persistent (bacteriostatic) efficacy otherwise the oral flora will colonize the tooth surface and 
establish a new biofilm again shortly after the antiseptic application (ADDY, MAROM, 2008). 
Collectively, both antimicrobial agents CHX and OCT have this anti-biofilm effect through several 
effective antibacterial mechanisms. The first mechanism is bactericidal in nature, whereby CHX and 
OCT destroy the oral microorganisms either in saliva, which are trying to attach to the tooth surface, or 
in the already attached bacterial biofilms. The second mechanism is the bacteriostatic activity, whereby 
CHX and OCT are able to damage the oral bacteria and prevent them from proliferation even for an 
extended time after application. Furthermore, it was proved in the retention study that CHX adsorbs at 
the pellicle-coated tooth surface and therefor it can prevent the attachment of oral bacteria and damage 
them.  
Lastly, according to the FM evaluation in the present study, 0.1% OCT was similar to the 0.2% 
CHX and more active than 0.1% CHX at both evaluation times 24 and 48 h in regards to the anti-biofilm 
effects. 
The TEM quantitative analyses revealed that the mean biofilm thicknesses were 4 and 12 µm after 
24 and 48 h of intraoral exposure, respectively, under the control conditions and water rinsing. In 
contrast, the TEM images showed that CHX and OCT rinsing caused a significant reduction in both the 
biofilm thickness and amount of bacteria in comparison with water rinsing. Similarly, it was reported 
in a former experiment by using confocal microscopy that CHX can produce an 89% reduction in 
biofilm thickness on glass discs (AUSCHILL et al., 2005).  
Additionally, through qualitative analyses, electron microscopy images showed more cellular 
ghosts on the CHX-treated specimens as compared to those found in the control enamel specimens. In 
some parts on the enamel surface, no loss of cytoplasmic ingredient could be found, because the cell 
walls were intact, surrounding the cytoplasm of a coagulated appearance. This is in agreement with 
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former experiments demonstrating that CHX caused leakage of cytoplasmic constituents and cytoplasm 
coagulation (HUGO, LONGWORTH, 1965; HUGO, LONGWORTH, 1966; BRECX, THEILADE, 
1984). Furthermore, it was stated that CHX induced a general perturbation of lipid bilayer membranes 
(GILBERT, MOORE, 2005) causing the bacterial membrane to lose its structural integrity 
(CHAWNER, GILBERT, 1989; VITKOV et al., 2005). 
Interestingly, in cases of treated specimens and unique to the control specimens, only a small 
increase in the biofilm thickness and the number of microbial cells was seen between 24 and 48 h of 
intraoral exposure, confirming a retarded oral biofilm development on the enamel induced by CHX or 
OCT application. This finding could suggest that with continued exposure to the antibacterial rinses 
twice daily used in the current work, this could be the maximal thickness of the bacterial layer that can 
develop. This finding indicates the importance of CHX or OCT rinses for biofilm control focused on 
persons incapable to reach appropriate oral hygiene levels or after oral surgical procedures where the 
usual hygiene measures are restricted. 
It is important to mention that an increased pellicle thickness of unstructured loose material 
covering the CHX treated specimens was observed in the current study (Fig. 17 C, Fig. 18 G and H). It 
was reported in a former experiment that CHX application even at a low concentration (0.012%) 
increases the adsorption of proteins on the enamel specimens (DE SOUZA-E-SILVA et al., 2017). Such 
a finding can clarify why, in the present study, the pellicle sheet after the CHX application was thicker 
on the treated specimens compared to the control ones. Interestingly, it was found in the former study 
that many proteins with potential protective functions against caries and erosion such as proline-rich 
proteins, calcium-binding proteins, and statherin were among the increased number of adsorbed proteins 
detected after CHX rinsing (DE SOUZA-E-SILVA et al., 2017). Because of that, it might be stated that 
CHX treatment can lead not only to bacterial biofilm inhibition but also could increase the dental 
protective potential against caries lesions by the formation of a thicker proteinaceous protective coating. 
Since the ultrastructural alteration caused by OCT rinsing was not evaluated before, the present 
study delivers the first TEM images of oral biofilms formed on natural enamel surfaces treated by OCT 
solution in situ. The mean observation is in agreement with the LDS images; OCT was able to totally 
inhibit the bacterial adhesion on the test surfaces. Only an acquired enamel pellicle was seen on the 
TEM micrographs either at 24- or 48-h time points without any bacterial colonization. Such an 
interesting finding can be explained by the evident antibacterial effect of OCT over time which was 
proved to stay very active even when highly diluted. Whereas CHX lost its antimicrobial effect when 
diluted to lower than 10% of its original concentration (ROHRER et al., 2010). 
5.2.2.2 Chlorhexidine and octenidine rinsing disrupts mature dental biofilm 
Since the killing of bacterial biofilm does not automatically induce the elimination of the microbial 
rests, the biofilm disrupting effect is an important concept for anti-biofilm efficacy. In this context, it is 
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not only important for an agent to reduce the bacterial vitality but also to be able to disrupt the mature 
biofilm and clean the enamel surface. In this way, there will be neither residual resistant bacteria to 
reform a new bacterial biofilm nor largely dead colonies attached to the tooth surface which could act 
as a base for additional mediated adherence of salivary living microorganisms.  
The biofilm disrupting effect was evaluated in this study by using an experimental design where a 
mature biofilm was formed on the dental surfaces for 48 h and then the application of CHX or OCT 
rinsing solution was done twice daily to investigate the ability to detach previously adsorbed bacteria. 
After the first rinsing, an immediate significant reduction in the microbial vitality was observed. 
After further rinsing during the next 24 h, there was a more remarkable reduction in both the microbial 
vitality and bacterial colonization on the treated specimens.  
According to the LDS images, the reduction in biofilm vitality was detected after using both CHX 
concentrations and OCT. Whereas, the biofilm disruption effect, which is presented as a reduction in 
the biofilm coverage, was noticed only by 0.2% CHX and 0.1% OCT but not on the 0.1% CHX treated 
surfaces. That means 0.2% CHX and 0.1% OCT have more evident biofilm disruption activity than 
0.1% CHX. 
The significant reduction in biofilm vitality is due to the effective antibacterial properties of CHX 
and OCT as described before in the introduction. Additionally, 0.2% CHX and 0.1% OCT were able to 
disrupt the biofilm presumably by breaking the glycoproteins connections between the bacteria, as well 
as displacing calcium molecules, which are considered as the glue that binds biofilm particles together 
(RÖLLA, MELSEN, 1975). Furthermore, CHX and OCT are able to devitalize the planktonic 
organisms in saliva (KOCAK et al., 2009; DOGAN et al., 2009; COUSIDO et al., 2010; GARCÍA-
CABALLERO et al., 2013), thus reducing the number of bacteria available for adherence and form new 
biofilm layers.  
By electron microscopy analysis, a complex multi-layer biofilm was observed at 48 h of intraoral 
exposure in the absence of mechanical teeth cleaning (control surfaces). The majority of the 
microorganisms observed were cocci and rod-shaped bacteria. The microorganisms were found 
prevalently and well preserved, however, after the first rinsing with CHX as well as OCT an immediate 
effect was observed on the biofilm complexity. The biofilm disrupting effect was more evident at 72 h 
of intraoral exposure. This disrupting effect significantly reduced the biofilm thickness and the number 
of bacterial cells of the biofilm after two-times rinsing when compared with the biofilm formed on the 
control enamel surfaces at 48 h of intraoral exposure. Most of the bacterial cells on the biofilm treated 
with CHX and OCT lost their structural integrity as seen at higher magnifications after 72 h of intraoral 
exposure. Moreover, leakage of the cellular elements, precipitation, and coagulation of the cytoplasm 
of the treated bacteria were detected (Fig. 24 C–H, Fig. 25 C-H). 
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It is important to note that the disruption effect of 0.1% CHX rinsing was more obvious in the 
TEM analysis than FM/LDS analysis. While the 0.1% CHX failed to induce a clear reduction in the 
biofilm coverage on the treated surfaces, it was able to significantly reduce the biofilm thickness by 
almost 80% after only one rinsing (Fig. 26). The biofilm was changed from multilayer mature biofilm 
to monolayer biofilm. However, it was able to cover the whole enamel surface, causing no change in 
the biofilm coverage percentage in the FM/LDS analysis. In other words, the disruptive activity of 0.1% 
CHX was clearer in the TEM images and analysis indicating that after the rinse application, the maturity 
and the complexity of the biofilm were less dominant. Such results indicate clearly the importance of 
using different experimental techniques in the experimental design to have more detailed results to 
explain the mechanism of action of the oral antiseptics.  
In the case of 0.1% OCT, it was able to reduce the biofilm thickness of the mature biofilm by 
almost 90% after only one rinsing. The multilayer biofilm was not only changed to a monolayer but 
there were also many places on the enamel surface without any bacterial colonization, which is in 
agreement with the LDS results. Such a result was also obtained with 0.2% CHX rinsing where there 
were many places without any bacterial adhesion. 
Former experiments had evaluated the disruption potential of CHX against mature biofilms. 
However, these studies showed contradictory findings. García-Caballero and co-workers reported that 
rinsing the 48-h mature biofilms with 0.2% CHX solution for 30 s reduced the biofilm vitality from 
78% under the basic situation to 5% after CHX rinsing (GARCÍA-CABALLERO et al., 2013). A similar 
finding was also seen in another work where the ex vivo CHX application for one and 10 min induced 
a clear reduction of the microbial vitality from 67% under basal conditions to 2% and 0.7% after CHX 
application, respectively (VON OHLE et al., 2010). On the contrary, only a small and superficial 
antimicrobial activity was detected after extra oral rinsing of 48-h mature biofilm with 0.2% CHX 
for 60 s (ZAURA-ARITE et al., 2001). Important to note that the ex vivo application of CHX and the 
thicker biofilm in the aforementioned work could have a major role in producing such a minor activity 
of CHX. Similarly, there was a minor antibacterial effect even after 5 min CHX treatment of mature 
multispecies biofilms that were formed on bovine enamel specimens in vitro (PRATTEN et al., 1991).  
In agreement with our finding, OCT was quite effective at killing pre-formed biofilms of 
Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
Staphylococcus aureus (VRSA). The average biofilm thickness on the control specimens was 15 μm as 
seen in the confocal microscopy images, whereas the average thickness of OCT treated biofilms was 
1 μm. OCT was able to induce patchy breaks in the biofilm by causing a disruption of the bacterial 
colonies and a loss of the microbial cells (AMALARADJOU, VENKITANARAYANAN, 2014). 
Similarly, Junka and co-workers found that 1 min contact time of OCT is able to completely inactivate 
in vitro pre-formed biofilms of Pseudomonas aeruginosa and Staphylococcus aureus (JUNKA et al., 
2014).  
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Taking these aforementioned studies into consideration, the biofilm disruption activity was not 
well studied in the literature under real in situ conditions especially in the case of OCT, which was 
evaluated only in vitro. Because of that, our findings came to emphasize the importance of in situ studies 
and confirm for the first time the biofilm-disruptive potential of CHX and OCT under most natural 
conditions on enamel surfaces. Lastly, although OCT has significant antibacterial effects, further 
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5.3 Conclusions 
5.3.1 Conclusion of retention studies 
This work shows a new reliable, selective, and sensitive technique with appropriate determination limits 
for CHX detection without the need for time-consuming sample preparation. MALDI-TOF provides 
rational mass resolving power, high mass accuracy, and can be implemented in high throughput 
measurements, making this method a promising approach for detecting CHX or other antiseptics in 
samples from different oral locations and not only in saliva like previous studies. 
The current work also confirms the assumption that oral surfaces (dental pellicle and oral mucosa) 
are the main reservoirs of CHX in the oral cavity. With time, the CHX particles are desorbed from the 
oral surfaces toward the saliva to produce a persistent bacteriostatic effect in the whole oral cavity for 
an extended time.  
It is shown in this study that the retention of CHX is much higher after mouth rinsing comparing 
with toothpaste application. According to the retention values, CHX toothpaste with a minimum 
concentration of 0.12% should not be considered as an adequate and sufficient pharmacological 
treatment of periodontal diseases and could be applied only for high caries risk patients. When a 
significant reduction of oral bacteria is required, such as for oral surgery preparations or for the 
treatment of periodontal diseases, 0.2% CHX application for 60 s gives the best retention values, which 
can provide a direct and persistent antibacterial efficacy in the oral cavity. Also, according to the good 
retention values after the spray usage, this kind of CHX application can be recommended especially in 
particular cases such as physically and mentally handicapped people. 
5.3.2 Conclusion of anti-biofilm study 
It is concluded in the study that the formulation based on CHX in both concentrations 0.1% and 0.2% 
as well as 0.1% OCT agent have a significant effect on reducing biofilm formation, confirmed through 
the reduction of the oral bacterial colonization and bacterial vitality on the experimental specimens. 
Additionally, this study demonstrates an important biofilm disruption potential of the 0.2% CHX and 
0.1% OCT rinsing, since they are effective to dislodge pre-existing mature biofilms, even in the total 
absence of manual biofilm control. The findings of the present study confirm the effectiveness of 0.2% 
CHX and 0.1% OCT rinsing during the intra-oral evaluation and also highlight the importance of 
performing in situ researches to investigate the efficacy of antibacterial products.  
As a final conclusion, since 0.1% OCT is almost as effective as 0.2% CHX in the anti-biofilm 
activity, but with half of the concentration, i.e. theoretically lower long-term side effects, it may be 
considered as a potent alternative to CHX-based preparations. However, preference in clinical 
effectiveness between OCT and CHX will request direct comparisons of both agents in long term 
clinical studies. 
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